News Releases

Bausch Health currently incorporates a range of businesses focused on gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, and international pharmaceuticals. Documents and presentations issued prior to the spinoff can be found under the appropriate tab (by years) or in the archive section located on this page.

For more information about Bausch + Lomb, please click here

All Categories

Date Title Document
Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio Date 09/11/25 Title Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio Download PDF
Bausch Health’s Aesthetic Business, Solta Medical, Surpasses Milestone of 5 Million Skin Tightening Treatments with Thermage® Non-Surgical System Date 09/05/25 Title Bausch Health’s Aesthetic Business, Solta Medical, Surpasses Milestone of 5 Million Skin Tightening Treatments with Thermage® Non-Surgical System Download PDF
Bausch Health Launches YUN Probiotherapy™ ACN Skincare Line in Poland Date 09/01/25 Title Bausch Health Launches YUN Probiotherapy™ ACN Skincare Line in Poland Download PDF
Bausch Health Launches YUN Probiotherapy™ ACN Skincare Line in Poland (Polish) Date 09/01/25 Title Bausch Health Launches YUN Probiotherapy™ ACN Skincare Line in Poland (Polish) Download PDF
Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025 Date 08/26/25 Title Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025 Download PDF
Bausch Health, Canada Inc. treatment for acne vulgaris, PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel), now available through public drug plans of Quebec and Saskatchewan Date 08/21/25 Title Bausch Health, Canada Inc. treatment for acne vulgaris, PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel), now available through public drug plans of Quebec and Saskatchewan Download PDF
Bausch Health, Canada Inc. treatment for acne vulgaris, PrCABTREOMC (clindamycin phosphate, adapalene and benzoyl peroxide gel), now available through public drug plans of Quebec and Saskatchewan (French) Date 08/21/25 Title Bausch Health, Canada Inc. treatment for acne vulgaris, PrCABTREOMC (clindamycin phosphate, adapalene and benzoyl peroxide gel), now available through public drug plans of Quebec and Saskatchewan (French) Download PDF
Bausch Health Announces Increase in Shareholding by its Chairperson of the Board and Board Changes Date 08/15/25 Title Bausch Health Announces Increase in Shareholding by its Chairperson of the Board and Board Changes Download PDF
Bausch Health Announces 2025 Gastrointestinal Health Scholars Program Winners Date 08/07/25 Title Bausch Health Announces 2025 Gastrointestinal Health Scholars Program Winners Download PDF
Bausch Health Announces Second Quarter 2025 Results Date 07/30/25 Title Bausch Health Announces Second Quarter 2025 Results Download PDF
Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease Date 07/29/25 Title Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease Download PDF
Bausch Health to Reduce Debt by Approximately $900 Million Using Cash On Hand Date 07/28/25 Title Bausch Health to Reduce Debt by Approximately $900 Million Using Cash On Hand Download PDF
Bausch Health Announces the Appointment of Two New Members to Its Board of Directors Date 07/24/25 Title Bausch Health Announces the Appointment of Two New Members to Its Board of Directors Download PDF
Bausch Health Appoints New Chief Accounting Officer Date 07/10/25 Title Bausch Health Appoints New Chief Accounting Officer Download PDF
Bausch Health, Canada Inc. treatment for acne vulgaris, PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel), now available through public drug plans of Ontario, Nova Scotia and two federal programs Date 07/09/25 Title Bausch Health, Canada Inc. treatment for acne vulgaris, PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel), now available through public drug plans of Ontario, Nova Scotia and two federal programs Download PDF
Bausch Health, Canada Inc. treatment for acne vulgaris, PrCABTREOMC (clindamycin phosphate, adapalene and benzoyl peroxide gel), now available through public drug plans of Ontario, Nova Scotia and two federal programs (French) Date 07/09/25 Title Bausch Health, Canada Inc. treatment for acne vulgaris, PrCABTREOMC (clindamycin phosphate, adapalene and benzoyl peroxide gel), now available through public drug plans of Ontario, Nova Scotia and two federal programs (French) Download PDF
Bausch Health’s Gastroenterology Business, Salix Pharmaceuticals, Launches Fresh “I Wish I Knew” Campaign to Educate People About Xifaxan® (rifaximin) for Adults at Risk of Overt Hepatic Encephalopathy Recurrence Date 07/07/25 Title Bausch Health’s Gastroenterology Business, Salix Pharmaceuticals, Launches Fresh “I Wish I Knew” Campaign to Educate People About Xifaxan® (rifaximin) for Adults at Risk of Overt Hepatic Encephalopathy Recurrence Download PDF
Bausch Health to Announce Second Quarter 2025 Results on July 30 Date 07/02/25 Title Bausch Health to Announce Second Quarter 2025 Results on July 30 Download PDF
Bausch Health Partners with YUN to Bring Pioneering Microbiome Skincare to Poland (English) Date 06/23/25 Title Bausch Health Partners with YUN to Bring Pioneering Microbiome Skincare to Poland (English) Download PDF
Bausch Health nawiązuje współpracę z YUN, aby wprowadzić przełomową pielęgnację mikrobiomu skóry do Polski (Polish) Date 06/23/25 Title Bausch Health nawiązuje współpracę z YUN, aby wprowadzić przełomową pielęgnację mikrobiomu skóry do Polski (Polish) Download PDF
Bausch Health Announces 2025 Annual Meeting of Shareholder Results Date 05/14/25 Title Bausch Health Announces 2025 Annual Meeting of Shareholder Results Download PDF
Xifaxan® (rifaximin) Treatment Following Overt Hepatic Encephalopathy (OHE) Hospitalization Associated with Reduced Risk of 30-Day OHE Rehospitalization Date 05/06/25 Title Xifaxan® (rifaximin) Treatment Following Overt Hepatic Encephalopathy (OHE) Hospitalization Associated with Reduced Risk of 30-Day OHE Rehospitalization Download PDF
Bausch Health Announces First Quarter 2025 Results Date 04/30/25 Title Bausch Health Announces First Quarter 2025 Results Download PDF
Bausch Health Announces Health Canada Clearance of Solta Medical’s Thermage® FLX System (English) Date 04/29/25 Title Bausch Health Announces Health Canada Clearance of Solta Medical’s Thermage® FLX System (English) Download PDF
Bausch Health Announces Health Canada Clearance of Solta Medical’s Thermage® FLX System (French) Date 04/29/25 Title Bausch Health Announces Health Canada Clearance of Solta Medical’s Thermage® FLX System (French) Download PDF
Bausch Health Announces Launch of Solta Medical’s Fraxel FTX™ Date 04/25/25 Title Bausch Health Announces Launch of Solta Medical’s Fraxel FTX™ Download PDF
Bausch Health Announces Filing of Supplement to Proxy Statement Date 04/22/25 Title Bausch Health Announces Filing of Supplement to Proxy Statement Download PDF
U.S. District Court Grants Summary Judgment in Favor of FDA, Salix, and Teva, and Against Norwich Date 04/17/25 Title U.S. District Court Grants Summary Judgment in Favor of FDA, Salix, and Teva, and Against Norwich Download PDF
Bausch Health Announces Adoption of Shareholder Rights Plan Date 04/14/25 Title Bausch Health Announces Adoption of Shareholder Rights Plan Download PDF
Bausch Health Announces Ortho Dermatologics 2025 ASPIRE HIGHER Scholarship Program Date 04/10/25 Title Bausch Health Announces Ortho Dermatologics 2025 ASPIRE HIGHER Scholarship Program Download PDF
Patient Voices Highlight the Realities of Living with Irritable Bowel Syndrome During IBS Awareness Month Date 04/02/25 Title Patient Voices Highlight the Realities of Living with Irritable Bowel Syndrome During IBS Awareness Month Download PDF
Bausch Health to Announce First Quarter Results on April 30 Date 03/27/25 Title Bausch Health to Announce First Quarter Results on April 30 Download PDF
Bausch Health Announces Pricing of Upsized Private Offering of Senior Secured Notes Date 03/25/25 Title Bausch Health Announces Pricing of Upsized Private Offering of Senior Secured Notes Download PDF
Bausch Health Announces Conditional Redemption of Senior Notes Date 03/21/25 Title Bausch Health Announces Conditional Redemption of Senior Notes Download PDF
Bausch Health Announces Launch of Private Offering of Senior Secured Notes and Conditional Redemption of Senior Notes Date 03/19/25 Title Bausch Health Announces Launch of Private Offering of Senior Secured Notes and Conditional Redemption of Senior Notes Download PDF
Bausch Health Announces Launch of Syndication of New Senior Secured Credit Facilities Date 03/19/25 Title Bausch Health Announces Launch of Syndication of New Senior Secured Credit Facilities Download PDF
Bausch Health Announces Next Steps in Financing Initiative with J.P. Morgan Date 03/14/25 Title Bausch Health Announces Next Steps in Financing Initiative with J.P. Morgan Download PDF
Bausch Health Announces Fourth Quarter and Full Year 2024 Results Date 02/19/25 Title Bausch Health Announces Fourth Quarter and Full Year 2024 Results Download PDF
Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference Date 02/14/25 Title Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference Download PDF
Bausch Health Announces 2025 Salix Gastrointestinal Health Scholars Program Date 02/10/25 Title Bausch Health Announces 2025 Salix Gastrointestinal Health Scholars Program Download PDF
Bausch Health Provides Update on Strategic Alternatives Date 02/06/25 Title Bausch Health Provides Update on Strategic Alternatives Download PDF
Bausch Health to Announce Fourth Quarter and Full Year 2024 Results on February 19, 2025 Date 01/23/25 Title Bausch Health to Announce Fourth Quarter and Full Year 2024 Results on February 19, 2025 Download PDF
Bausch Health Statement on Selection of XIFAXAN® (rifaximin) for Inflation Reduction Act’s Medicare Negotiation Program Date 01/17/25 Title Bausch Health Statement on Selection of XIFAXAN® (rifaximin) for Inflation Reduction Act’s Medicare Negotiation Program Download PDF
Bausch Health Responds to Rumors of a Potential Sale of Bausch + Lomb Date 12/12/24 Title Bausch Health Responds to Rumors of a Potential Sale of Bausch + Lomb Download PDF
Bausch Health and Salix in Collaboration with Health Organizations Recognize the Second Annual Opioid-Induced Constipation (OIC) Awareness Day Date 12/05/24 Title Bausch Health and Salix in Collaboration with Health Organizations Recognize the Second Annual Opioid-Induced Constipation (OIC) Awareness Day Download PDF
Bausch Health Appoints New Chief Medical Officer and Head of R&D Date 12/02/24 Title Bausch Health Appoints New Chief Medical Officer and Head of R&D Download PDF
Bausch Health and Salix to present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a new investigational product designed to address serious complications of cirrhosis Date 11/18/24 Title Bausch Health and Salix to present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a new investigational product designed to address serious complications of cirrhosis Download PDF
Bausch Health Announces Third Quarter 2024 Results Date 10/30/24 Title Bausch Health Announces Third Quarter 2024 Results Download PDF
ACG Presidential Plenary to Highlight Analysis of Xifaxan® (rifaximin) Risk Reduction of Overt Hepatic Encephalopathy (OHE) Recurrence Date 10/28/24 Title ACG Presidential Plenary to Highlight Analysis of Xifaxan® (rifaximin) Risk Reduction of Overt Hepatic Encephalopathy (OHE) Recurrence Download PDF
Bausch Health to Announce Third Quarter 2024 Results on October 30, 2024 Date 10/09/24 Title Bausch Health to Announce Third Quarter 2024 Results on October 30, 2024 Download PDF
Bausch Health and Salix survey highlights urgent need for improved understanding of liver disease across healthcare provider disciplines as prevalence of cirrhosis rises Date 10/08/24 Title Bausch Health and Salix survey highlights urgent need for improved understanding of liver disease across healthcare provider disciplines as prevalence of cirrhosis rises Download PDF
Bausch Health Announces 2024 Gastrointestinal Health Scholars Program Winners Date 08/13/24 Title Bausch Health Announces 2024 Gastrointestinal Health Scholars Program Winners Download PDF
Bausch Health Announces Second Quarter 2024 Results Date 08/01/24 Title Bausch Health Announces Second Quarter 2024 Results Download PDF
Bausch Health Responds to Market Rumors Date 07/24/24 Title Bausch Health Responds to Market Rumors Download PDF
Bausch Health Welcomes Two New Members to the Executive Leadership Team Date 07/19/24 Title Bausch Health Welcomes Two New Members to the Executive Leadership Team Download PDF
Bausch Health to Announce Second Quarter 2024 Results on August 1, 2024 Date 07/11/24 Title Bausch Health to Announce Second Quarter 2024 Results on August 1, 2024 Download PDF
Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals Date 06/20/24 Title Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals Download PDF
Bausch Health Reports Promising R&D Trial Updates on Amiselimod and Scientific Data Presented at International Healthcare Conferences Date 06/14/24 Title Bausch Health Reports Promising R&D Trial Updates on Amiselimod and Scientific Data Presented at International Healthcare Conferences Download PDF
Bausch Health, Canada Inc. announces additional public drug plan listings for PrUCERIS® (budesonide) aerosol foam to treat mild to moderate distal ulcerative colitis in adults Date 05/23/24 Title Bausch Health, Canada Inc. announces additional public drug plan listings for PrUCERIS® (budesonide) aerosol foam to treat mild to moderate distal ulcerative colitis in adults Download PDF
Salix to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at Digestive Disease Week 2024 Date 05/17/24 Title Salix to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at Digestive Disease Week 2024 Download PDF
Bausch Health Announces 2024 Annual Meeting of Shareholder Results Date 05/15/24 Title Bausch Health Announces 2024 Annual Meeting of Shareholder Results Download PDF
Bausch Health Announces Updates Related to Norwich XIFAXAN Matters Date 05/14/24 Title Bausch Health Announces Updates Related to Norwich XIFAXAN Matters Download PDF
Salix Pharmaceuticals announces Bellamy Young as Spokesperson for Xifaxan® (rifaximin) Date 05/09/24 Title Salix Pharmaceuticals announces Bellamy Young as Spokesperson for Xifaxan® (rifaximin) Download PDF
Bausch Health Announces First Quarter 2024 Results Date 05/02/24 Title Bausch Health Announces First Quarter 2024 Results Download PDF
Bausch Health to Announce First-Quarter 2024 Results on May 2 Date 04/11/24 Title Bausch Health to Announce First-Quarter 2024 Results on May 2 Download PDF
Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029 Date 04/11/24 Title Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029 Download PDF
Acne vulgaris treatment PrARAZLO™ (tazarotene lotion, 0.045%) now available to patients through British Columbia PharmaCare public drug plan Date 04/11/24 Title Acne vulgaris treatment PrARAZLO™ (tazarotene lotion, 0.045%) now available to patients through British Columbia PharmaCare public drug plan Download PDF
Bausch Health Announces Patent Lawsuit Against Amneal Pharmaceuticals Date 04/05/24 Title Bausch Health Announces Patent Lawsuit Against Amneal Pharmaceuticals Download PDF
Bausch Health, Canada Inc. announces first public drug plan listings for PrUCERIS® (budesonide) aerosol foam to help address the unmet need for the treatment of mild to moderate distal ulcerative colitis in adults Date 04/03/24 Title Bausch Health, Canada Inc. announces first public drug plan listings for PrUCERIS® (budesonide) aerosol foam to help address the unmet need for the treatment of mild to moderate distal ulcerative colitis in adults Download PDF
Based on a New Survey, More Than Half of Surveyed IBS/CIC Patients Feel Alone in Their Experience but Also Find That Social Media Helps Create a Community and Inspires Healthcare Provider Conversations Date 04/02/24 Title Based on a New Survey, More Than Half of Surveyed IBS/CIC Patients Feel Alone in Their Experience but Also Find That Social Media Helps Create a Community and Inspires Healthcare Provider Conversations Download PDF
Salix Pharmaceuticals Announces a Phase 2 Investigator-Initiated Study of RELISTOR® (methylnaltrexone bromide: MNTX) in Patients with Resectable Head and Neck Squamous Cell Carcinoma Date 03/06/24 Title Salix Pharmaceuticals Announces a Phase 2 Investigator-Initiated Study of RELISTOR® (methylnaltrexone bromide: MNTX) in Patients with Resectable Head and Neck Squamous Cell Carcinoma Download PDF
New Survey Finds More Than Half of Past U.S. Colonoscopy Patients Wish They Had Known More Information About Colonoscopies Including Prep Medication Options and How to Prepare for the Procedure Date 03/05/24 Title New Survey Finds More Than Half of Past U.S. Colonoscopy Patients Wish They Had Known More Information About Colonoscopies Including Prep Medication Options and How to Prepare for the Procedure Download PDF
Bausch Health Companies to Present at Cowen Annual Health Care Conference Date 03/01/24 Title Bausch Health Companies to Present at Cowen Annual Health Care Conference Download PDF
Bausch Health Announces Fourth-Quarter and Full-Year 2023 Results Date 02/22/24 Title Bausch Health Announces Fourth-Quarter and Full-Year 2023 Results Download PDF
Salix Announces 2024 Gastrointestinal Health Scholars Program Date 02/12/24 Title Salix Announces 2024 Gastrointestinal Health Scholars Program Download PDF
Bausch Health Announces Board Refreshment Date 02/01/24 Title Bausch Health Announces Board Refreshment Download PDF
Bausch Health to Announce Fourth-Quarter and Full-Year 2023 Results on Feb. 22 Date 02/01/24 Title Bausch Health to Announce Fourth-Quarter and Full-Year 2023 Results on Feb. 22 Download PDF
CABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel for the Treatment of Acne Vulgaris Now Available in the U.S. Date 01/30/24 Title CABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel for the Treatment of Acne Vulgaris Now Available in the U.S. Download PDF
Solta Medical’s Thermage® FLX and TR-4 Return Pad Receive Registration Certifications in China Date 01/18/24 Title Solta Medical’s Thermage® FLX and TR-4 Return Pad Receive Registration Certifications in China Download PDF
Court of Appeals for the Federal Circuit Hears Oral Arguments on Patent Dispute Date 01/08/24 Title Court of Appeals for the Federal Circuit Hears Oral Arguments on Patent Dispute Download PDF
Bausch Health Announces Positive Topline Results From Global Phase 2 Study Evaluating Amiselimod (an S1P antagonist) to Treat Ulcerative Colitis Date 12/21/23 Title Bausch Health Announces Positive Topline Results From Global Phase 2 Study Evaluating Amiselimod (an S1P antagonist) to Treat Ulcerative Colitis Download PDF
DUOBRII™ lotion to treat moderate to severe plaque psoriasis now available through Quebec’s public drug plan Date 12/18/23 Title DUOBRII™ lotion to treat moderate to severe plaque psoriasis now available through Quebec’s public drug plan Download PDF
Salix In Collaboration With The U.S. Pain Foundation And The International Foundation For Gastrointestinal Disorders Establish The Inaugural Opioid- Induced Constipation (Oic) Awareness Day Date 12/05/23 Title Salix In Collaboration With The U.S. Pain Foundation And The International Foundation For Gastrointestinal Disorders Establish The Inaugural Opioid- Induced Constipation (Oic) Awareness Day Download PDF
The Absence of an Overt Hepatic Encephalopathy (OHE)-Specific Diagnosis Code May Result in Increased OHE-Related Length of Stay and Hospitalization-Related Costs Due to OHE Rate Underestimation, According to New Analysis Date 11/10/23 Title The Absence of an Overt Hepatic Encephalopathy (OHE)-Specific Diagnosis Code May Result in Increased OHE-Related Length of Stay and Hospitalization-Related Costs Due to OHE Rate Underestimation, According to New Analysis Download PDF
As Daylight Saving Time Comes to a Close, Bausch Health Champions Mental Health with a Spotlight on Preventing Seasonal Affective Disorder (SAD) Date 11/08/23 Title As Daylight Saving Time Comes to a Close, Bausch Health Champions Mental Health with a Spotlight on Preventing Seasonal Affective Disorder (SAD) Download PDF
Bausch Health Announces Third-Quarter 2023 Results Date 11/02/23 Title Bausch Health Announces Third-Quarter 2023 Results Download PDF
U.S. District Court Dismisses Norwich’s Lawsuit Against the FDA Date 11/01/23 Title U.S. District Court Dismisses Norwich’s Lawsuit Against the FDA Download PDF
Bausch Health Unveils "Looking Forward" – A New DTC Television Campaign for Seasonal Affective Disorder (SAD) Date 10/25/23 Title Bausch Health Unveils "Looking Forward" – A New DTC Television Campaign for Seasonal Affective Disorder (SAD) Download PDF
FDA Approves CabtreoTM (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel For The Treatment Of Acne Vulgaris In Patients Twelve Years Of Age And Older Date 10/20/23 Title FDA Approves CabtreoTM (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel For The Treatment Of Acne Vulgaris In Patients Twelve Years Of Age And Older Download PDF
New Analysis Indicates That a Majority of Overt Hepatic Encephalopathy (OHE) Patients May Face Delays in Treatment Initiation and Gaps During Treatment for Access to Treatment Indicated to Reduce Risk for OHE Recurrence Date 10/17/23 Title New Analysis Indicates That a Majority of Overt Hepatic Encephalopathy (OHE) Patients May Face Delays in Treatment Initiation and Gaps During Treatment for Access to Treatment Indicated to Reduce Risk for OHE Recurrence Download PDF
Bausch Health to Announce Third-Quarter 2023 Results on Nov. 2 Date 10/12/23 Title Bausch Health to Announce Third-Quarter 2023 Results on Nov. 2 Download PDF
Salix Pharmaceuticals Releases Liver Health Annual Trends Report Identifying Increase In Chronic Liver Disease And Cirrhosis-related Deaths Marking These As Ninth Leading Cause Of Death In U.S. Date 10/10/23 Title Salix Pharmaceuticals Releases Liver Health Annual Trends Report Identifying Increase In Chronic Liver Disease And Cirrhosis-related Deaths Marking These As Ninth Leading Cause Of Death In U.S. Download PDF
Salix Pharmaceuticals partners with Bellamy Young Date 10/04/23 Title Salix Pharmaceuticals partners with Bellamy Young Download PDF
Bausch Health’s Bausch + Lomb Announces Completion of the Acquisition of XIIDRA® Date 09/29/23 Title Bausch Health’s Bausch + Lomb Announces Completion of the Acquisition of XIIDRA® Download PDF
League of United Latin American Citizens (LULAC) Joins OraPharma in the Fight Against Gum Disease Date 09/21/23 Title League of United Latin American Citizens (LULAC) Joins OraPharma in the Fight Against Gum Disease Download PDF
Bausch Health announces CFO Transition Plan Date 09/18/23 Title Bausch Health announces CFO Transition Plan Download PDF
New Bausch Health treatment PrUCERIS® (budesonide) aerosol foam now available across Canada to treat mild to moderate distal ulcerative colitis in adults Date 09/12/23 Title New Bausch Health treatment PrUCERIS® (budesonide) aerosol foam now available across Canada to treat mild to moderate distal ulcerative colitis in adults Download PDF
Bausch Health’s Bausch + Lomb Announces Launch of Proposed Financing for Acquisition of XIIDRA® Date 09/11/23 Title Bausch Health’s Bausch + Lomb Announces Launch of Proposed Financing for Acquisition of XIIDRA® Download PDF
Bausch Health’s Bausch + Lomb Announces Disclosure of Historical and Pro Forma Financial Information With Respect to Acquisition of XIIDRA® Date 09/06/23 Title Bausch Health’s Bausch + Lomb Announces Disclosure of Historical and Pro Forma Financial Information With Respect to Acquisition of XIIDRA® Download PDF
Bausch Health Announces Second-Quarter 2023 Results, other key updates from the Quarter, and raises Full-Year 2023 Revenue Outlook Date 08/03/23 Title Bausch Health Announces Second-Quarter 2023 Results, other key updates from the Quarter, and raises Full-Year 2023 Revenue Outlook Download PDF
Ortho Dermatologics Announces 2023 Aspire Higher Scholarship Recipients Date 07/27/23 Title Ortho Dermatologics Announces 2023 Aspire Higher Scholarship Recipients Download PDF
Bausch Health to Announce Second-Quarter 2023 Results on Aug. 3 Date 07/13/23 Title Bausch Health to Announce Second-Quarter 2023 Results on Aug. 3 Download PDF
Salix Announces 2023 Gastrointestinal Health Scholars Program Winners Date 07/11/23 Title Salix Announces 2023 Gastrointestinal Health Scholars Program Winners Download PDF
OraPharma to Participate in the First-Ever Research and Technology Pavilion Sponsored by Pacific Dental Services® at the American Dental Hygienists’ Association (ADHA®) Annual Conference Date 07/07/23 Title OraPharma to Participate in the First-Ever Research and Technology Pavilion Sponsored by Pacific Dental Services® at the American Dental Hygienists’ Association (ADHA®) Annual Conference Download PDF
Bausch Health Enters Into $600 Million Financing Facility With KKR Date 07/07/23 Title Bausch Health Enters Into $600 Million Financing Facility With KKR Download PDF
Bausch Health’s Bausch + Lomb to Acquire Novartis’ XIIDRA® Date 06/30/23 Title Bausch Health’s Bausch + Lomb to Acquire Novartis’ XIIDRA® Download PDF
Salix to Present Data from XIFAXAN® (Rifaximin) Clinical Research at EASL's International Liver Congress™ 2023 Date 06/19/23 Title Salix to Present Data from XIFAXAN® (Rifaximin) Clinical Research at EASL's International Liver Congress™ 2023 Download PDF
Bausch Health Responds to Norwich’s ANDA Tentative Approval and Lawsuit Against United States Food and Drug Administration Date 06/06/23 Title Bausch Health Responds to Norwich’s ANDA Tentative Approval and Lawsuit Against United States Food and Drug Administration Download PDF
OraPharma and Alex Rodriguez Team Up to Raise Awareness About the Importance of Managing Gum Disease Date 05/31/23 Title OraPharma and Alex Rodriguez Team Up to Raise Awareness About the Importance of Managing Gum Disease Download PDF
New Clinical Study Suggests the Use of OraPharma’s ARESTIN® (minocycline HCl) Microspheres, 1mg May Decrease Certain Pathogens in Adults with Periodontitis Date 05/18/23 Title New Clinical Study Suggests the Use of OraPharma’s ARESTIN® (minocycline HCl) Microspheres, 1mg May Decrease Certain Pathogens in Adults with Periodontitis Download PDF
U.S. District Court Upholds Final Judgment for XIFAXAN® 550 mg That Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029 Date 05/17/23 Title U.S. District Court Upholds Final Judgment for XIFAXAN® 550 mg That Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029 Download PDF
Bausch Health Announces 2023 Annual Meeting of Shareholder Results Date 05/17/23 Title Bausch Health Announces 2023 Annual Meeting of Shareholder Results Download PDF
Bausch Health Observes Mental Health Awareness Month Date 05/10/23 Title Bausch Health Observes Mental Health Awareness Month Download PDF
Salix Pharmaceuticals To Deliver Podium Presentation At Digestive Disease Week® 2023 Date 05/08/23 Title Salix Pharmaceuticals To Deliver Podium Presentation At Digestive Disease Week® 2023 Download PDF
Bausch Health Announces First-Quarter 2023 Results Date 05/04/23 Title Bausch Health Announces First-Quarter 2023 Results Download PDF
Ortho Dermatologics Announces U.S. Food and Drug Administration New Drug Application Filing Acceptance for Investigational Acne Treatment IDP-126 Gel Date 05/01/23 Title Ortho Dermatologics Announces U.S. Food and Drug Administration New Drug Application Filing Acceptance for Investigational Acne Treatment IDP-126 Gel Download PDF
Salix Partners with the Colorectal Cancer Alliance on Community Screening Program Date 04/24/23 Title Salix Partners with the Colorectal Cancer Alliance on Community Screening Program Download PDF
Bausch Health to Announce First-Quarter 2023 Results on May 4 Date 04/13/23 Title Bausch Health to Announce First-Quarter 2023 Results on May 4 Download PDF
More than half of IBS patients surveyed report waiting more than one year before discussing IBS symptoms with their healthcare provider Date 04/04/23 Title More than half of IBS patients surveyed report waiting more than one year before discussing IBS symptoms with their healthcare provider Download PDF
Bausch Health Announces Changes to its Board of Directors Date 03/01/23 Title Bausch Health Announces Changes to its Board of Directors Download PDF
Bausch Health Announces Fourth-Quarter and Full-Year 2022 Results Date 02/23/23 Title Bausch Health Announces Fourth-Quarter and Full-Year 2022 Results Download PDF
Salix Announces 2023 Gastrointestinal Health Scholars Program Date 02/13/23 Title Salix Announces 2023 Gastrointestinal Health Scholars Program Download PDF
Bausch Health to Announce Fourth-Quarter and Full-Year 2022 Results on Feb. 23 Date 02/01/23 Title Bausch Health to Announce Fourth-Quarter and Full-Year 2022 Results on Feb. 23 Download PDF
First tazarotene lotion treatment for acne vulgaris, ARAZLO™ (tazarotene lotion, 0.045%), now available to patients through Quebec, Ontario, Alberta, Saskatchewan and federal NIHB public drug plans Date 12/22/22 Title First tazarotene lotion treatment for acne vulgaris, ARAZLO™ (tazarotene lotion, 0.045%), now available to patients through Quebec, Ontario, Alberta, Saskatchewan and federal NIHB public drug plans Download PDF
Bausch Health Wins DUOBRII® and BRYHALI® Patent Infringement Case Date 12/02/22 Title Bausch Health Wins DUOBRII® and BRYHALI® Patent Infringement Case Download PDF
Salix Pharmaceuticals Culminates Year-Long Constipation Awareness Campaign with New Social Media and Digital Initiatives Empowering Patients to Discuss Their Symptoms with a Health Care Provider Date 12/01/22 Title Salix Pharmaceuticals Culminates Year-Long Constipation Awareness Campaign with New Social Media and Digital Initiatives Empowering Patients to Discuss Their Symptoms with a Health Care Provider Download PDF
Bausch Health Announces the Unrestricting of Bausch + Lomb Under Bausch Health Debt Covenants Date 11/29/22 Title Bausch Health Announces the Unrestricting of Bausch + Lomb Under Bausch Health Debt Covenants Download PDF
Salix Will Present Rifaximin Data at AASLD's The Liver Meeting(R) 2022 Date 11/04/22 Title Salix Will Present Rifaximin Data at AASLD's The Liver Meeting(R) 2022 Download PDF
Bausch Health Companies Inc. Announces Third-Quarter 2022 Results Date 11/03/22 Title Bausch Health Companies Inc. Announces Third-Quarter 2022 Results Download PDF
Ortho Dermatologics to Present New Data at the 2022 Innovations in Dermatology Conference Date 11/01/22 Title Ortho Dermatologics to Present New Data at the 2022 Innovations in Dermatology Conference Download PDF
Ortho Dermatologics Announces U.S. Launch of the Podiatry Board Review Challenge Date 10/31/22 Title Ortho Dermatologics Announces U.S. Launch of the Podiatry Board Review Challenge Download PDF
Salix Will Present XIFAXAN(R) (Rifaximin), TRULANCE(R) (Plecanatide) and RELISTOR(R) (Methylnaltrexone Bromide) Data at The American College of Gastroenterology(R) 2022 Annual Scientific Meeting Date 10/24/22 Title Salix Will Present XIFAXAN(R) (Rifaximin), TRULANCE(R) (Plecanatide) and RELISTOR(R) (Methylnaltrexone Bromide) Data at The American College of Gastroenterology(R) 2022 Annual Scientific Meeting Download PDF
Ortho Dermatologics To Present New Data at the 2022 Fall Clinical Dermatology Conference Date 10/20/22 Title Ortho Dermatologics To Present New Data at the 2022 Fall Clinical Dermatology Conference Download PDF
Bausch Health to Announce Third Quarter 2022 Results on Nov. 3 Date 10/13/22 Title Bausch Health to Announce Third Quarter 2022 Results on Nov. 3 Download PDF
Salix Pharmaceuticals Releases Liver Health Annual Trends Report Underscoring Challenges in Caring for Growing Chronic Liver Disease and Cirrhotic Patient Population Date 10/12/22 Title Salix Pharmaceuticals Releases Liver Health Annual Trends Report Underscoring Challenges in Caring for Growing Chronic Liver Disease and Cirrhotic Patient Population Download PDF
Seasonal Affective Disorder (SAD) Is Now a Recognized Diagnosis in the CMS Tabular Index, Accessible to Prescribers Oct. 1, 2022 Date 10/05/22 Title Seasonal Affective Disorder (SAD) Is Now a Recognized Diagnosis in the CMS Tabular Index, Accessible to Prescribers Oct. 1, 2022 Download PDF
Salix Pharmaceuticals Applauds Implementation of K76.82 – a New ICD-10 Code for Hepatic Encephalopathy Date 10/03/22 Title Salix Pharmaceuticals Applauds Implementation of K76.82 – a New ICD-10 Code for Hepatic Encephalopathy Download PDF
Bausch Health Announces Final Results and Expiration of Exchange Offers and Consent Solicitations Date 09/28/22 Title Bausch Health Announces Final Results and Expiration of Exchange Offers and Consent Solicitations Download PDF
Bausch Health Announces Early Exchange Offer Results for Exchange Offers and Consent Solicitations Date 09/14/22 Title Bausch Health Announces Early Exchange Offer Results for Exchange Offers and Consent Solicitations Download PDF
Bausch Health Responds to Norwich Pharmaceuticals Tentative FDA Approval for a 200 mg Rifaximin Date 09/09/22 Title Bausch Health Responds to Norwich Pharmaceuticals Tentative FDA Approval for a 200 mg Rifaximin Download PDF
Bausch Health Clarifies Release Provisions Related to its Exchange Offers and Consent Solicitations Date 09/08/22 Title Bausch Health Clarifies Release Provisions Related to its Exchange Offers and Consent Solicitations Download PDF
Bausch Health Announces Exchange Offers and Consent Solicitations for Certain Existing Senior Notes with Support from Approximately 23% of Outstanding Existing Senior Notes Date 08/30/22 Title Bausch Health Announces Exchange Offers and Consent Solicitations for Certain Existing Senior Notes with Support from Approximately 23% of Outstanding Existing Senior Notes Download PDF
Bausch Health Continuing Process Toward Separating Bausch + Lomb Date 08/22/22 Title Bausch Health Continuing Process Toward Separating Bausch + Lomb Download PDF
Bausch Health to Appeal XIFAXAN® Patent Decision to U.S. Court of Appeals for the Federal Circuit Date 08/10/22 Title Bausch Health to Appeal XIFAXAN® Patent Decision to U.S. Court of Appeals for the Federal Circuit Download PDF
Salix Supports CMS Announcement of First ICD-10 Code for Hepatic Encephalopathy (HE) Date 08/10/22 Title Salix Supports CMS Announcement of First ICD-10 Code for Hepatic Encephalopathy (HE) Download PDF
Bausch Health Announces Second-Quarter 2022 Results Date 08/09/22 Title Bausch Health Announces Second-Quarter 2022 Results Download PDF
Bausch Health Provides Update Following Oral Order in XIFAXAN® Patent Litigation Date 07/28/22 Title Bausch Health Provides Update Following Oral Order in XIFAXAN® Patent Litigation Download PDF
Bausch Health Companies Inc. Will Release Second-Quarter 2022 Financial Results on Aug. 9 Date 07/27/22 Title Bausch Health Companies Inc. Will Release Second-Quarter 2022 Financial Results on Aug. 9 Download PDF
Salix Announces 2022 Gastrointestinal Health Scholars Program Winners Date 07/13/22 Title Salix Announces 2022 Gastrointestinal Health Scholars Program Winners Download PDF
Bausch Health Announces 2022 Annual Meeting of Shareholder Results, Updates to its Board of Directors Date 06/23/22 Title Bausch Health Announces 2022 Annual Meeting of Shareholder Results, Updates to its Board of Directors Download PDF
Bausch Health Issues Form 8-K for 2022 Annual Meeting of Shareholders Presentation Date 06/21/22 Title Bausch Health Issues Form 8-K for 2022 Annual Meeting of Shareholders Presentation Download PDF
Salix to Share New Data from XIFAXAN® (Rifaximin) Clinical Research at EASL's International Liver Congress™ 2022 Date 06/20/22 Title Salix to Share New Data from XIFAXAN® (Rifaximin) Clinical Research at EASL's International Liver Congress™ 2022 Download PDF
Bausch Health Provides Update on Solta Medical Date 06/16/22 Title Bausch Health Provides Update on Solta Medical Download PDF
Salix Pharmaceuticals To Share New Data At Digestive Disease Week® 2022 Date 05/18/22 Title Salix Pharmaceuticals To Share New Data At Digestive Disease Week® 2022 Download PDF
Bausch Health Announces Participation In Upcoming Investor Conferences Date 05/11/22 Title Bausch Health Announces Participation In Upcoming Investor Conferences Download PDF
Bausch Health And Bausch + Lomb Corporation Announce Closing Of Initial Public Offering Of Bausch + Lomb And Related Debt Transactions Date 05/10/22 Title Bausch Health And Bausch + Lomb Corporation Announce Closing Of Initial Public Offering Of Bausch + Lomb And Related Debt Transactions Download PDF
Bausch Health Companies Inc. Announces First-Quarter 2022 Results Date 05/10/22 Title Bausch Health Companies Inc. Announces First-Quarter 2022 Results Download PDF
Bausch Health Announces Thomas J. Appio As Chief Executive Officer Date 05/06/22 Title Bausch Health Announces Thomas J. Appio As Chief Executive Officer Download PDF
Bausch + Lomb Corporation Announces Pricing of IPO Date 05/05/22 Title Bausch + Lomb Corporation Announces Pricing of IPO Download PDF
Bausch + Lomb Presents Data from Second Pivotal Phase 3 Trial of Investigational Treatment NOV03 (Perfluorohexyloctane) at the Association for Research in Vision and Ophthalmology Annual Meeting Date 05/03/22 Title Bausch + Lomb Presents Data from Second Pivotal Phase 3 Trial of Investigational Treatment NOV03 (Perfluorohexyloctane) at the Association for Research in Vision and Ophthalmology Annual Meeting Download PDF
Bausch Health Companies Inc. Will Release First-Quarter 2022 Financial Results On May 10 Date 04/29/22 Title Bausch Health Companies Inc. Will Release First-Quarter 2022 Financial Results On May 10 Download PDF
Bausch + Lomb Corporation Announces Launch of IPO and Roadshow Date 04/28/22 Title Bausch + Lomb Corporation Announces Launch of IPO and Roadshow Download PDF
Bausch Health Enters Into Arrangement Agreement with Bausch + Lomb Corporation in Connection with Previously Announced Proposed Separation Date 04/28/22 Title Bausch Health Enters Into Arrangement Agreement with Bausch + Lomb Corporation in Connection with Previously Announced Proposed Separation Download PDF
Bausch + Lomb Will Present New Scientific Data and Analyses on Products and Pipeline Programs During the Association for Research in Vision and Ophthalmology Meeting Date 04/28/22 Title Bausch + Lomb Will Present New Scientific Data and Analyses on Products and Pipeline Programs During the Association for Research in Vision and Ophthalmology Meeting Download PDF
Ortho Dermatologics Will Present Data at the 2022 Florida Society of Dermatology Physician Assistants New Wave Dermatology Conference Date 04/27/22 Title Ortho Dermatologics Will Present Data at the 2022 Florida Society of Dermatology Physician Assistants New Wave Dermatology Conference Download PDF
Bausch + Lomb Presents Data from First Pivotal Phase 3 Trial of Investigational Treatment NOV03 (Perfluorohexyloctane) at the American Society of Cataract and Refractive Surgery Annual Meeting Date 04/25/22 Title Bausch + Lomb Presents Data from First Pivotal Phase 3 Trial of Investigational Treatment NOV03 (Perfluorohexyloctane) at the American Society of Cataract and Refractive Surgery Annual Meeting Download PDF
Bausch + Lomb Reports More Than 48 Million Units of Contact Lens, Eye Care and Lens Care Materials Recycled Through ONE by ONE and Biotrue® Eye Care Recycling Programs Date 04/21/22 Title Bausch + Lomb Reports More Than 48 Million Units of Contact Lens, Eye Care and Lens Care Materials Recycled Through ONE by ONE and Biotrue® Eye Care Recycling Programs Download PDF
Bausch + Lomb Corporation Seeking to Enter Into New Credit Facilities to Facilitate Previously Announced Separation from Bausch Health Date 04/20/22 Title Bausch + Lomb Corporation Seeking to Enter Into New Credit Facilities to Facilitate Previously Announced Separation from Bausch Health Download PDF
Bausch + Lomb Will Present New Scientific Data During the American Society of Cataract and Refractive Surgery Annual Meeting Date 04/18/22 Title Bausch + Lomb Will Present New Scientific Data During the American Society of Cataract and Refractive Surgery Annual Meeting Download PDF
HALF OF IBS PATIENTS SURVEYED REPORT IBS SYMPTOMS MORE CHALLENGING TO MANAGE IN THE PAST YEAR Date 04/04/22 Title HALF OF IBS PATIENTS SURVEYED REPORT IBS SYMPTOMS MORE CHALLENGING TO MANAGE IN THE PAST YEAR Download PDF
Bausch Health Will Reduce Debt By $200 Million Date 03/29/22 Title Bausch Health Will Reduce Debt By $200 Million Download PDF
Bausch + Lomb and Clearside Biomedical Announce the U.S. Commercial Launch of XIPERE® (Triamcinolone Acetonide Injectable Suspension) For Suprachoroidal Use for the Treatment of Macular Edema Associated with Uveitis Date 03/28/22 Title Bausch + Lomb and Clearside Biomedical Announce the U.S. Commercial Launch of XIPERE® (Triamcinolone Acetonide Injectable Suspension) For Suprachoroidal Use for the Treatment of Macular Edema Associated with Uveitis Download PDF
New Data on Cost Impact of Treating Opioid-Induced Constipation (OIC) with FDA-Approved Medications, Including Salix's RELISTOR® Subcutaneous Injection (Methylnaltrexone Bromide), in The Emergency Department Is Published in Advances In Therapy Date 03/24/22 Title New Data on Cost Impact of Treating Opioid-Induced Constipation (OIC) with FDA-Approved Medications, Including Salix's RELISTOR® Subcutaneous Injection (Methylnaltrexone Bromide), in The Emergency Department Is Published in Advances In Therapy Download PDF
Gary Gemignani Will Join Solta Medical Corporation As Chief Financial Officer Date 03/22/22 Title Gary Gemignani Will Join Solta Medical Corporation As Chief Financial Officer Download PDF
Ortho Dermatologics Will Present New Data at the 2022 American Academy of Dermatology Annual Meeting Date 03/22/22 Title Ortho Dermatologics Will Present New Data at the 2022 American Academy of Dermatology Annual Meeting Download PDF
Bausch Health Announces Participation in Upcoming Investor Conferences Date 03/03/22 Title Bausch Health Announces Participation in Upcoming Investor Conferences Download PDF
Ortho Dermatologics Now Accepting Applications for 2022 Aspire Higher Scholarship Program Date 03/02/22 Title Ortho Dermatologics Now Accepting Applications for 2022 Aspire Higher Scholarship Program Download PDF
Salix and Colon Cancer Coalition Join Forces for 'Faces of Blue' Story Series to Raise Awareness of Colorectal Cancer Screenings Date 03/01/22 Title Salix and Colon Cancer Coalition Join Forces for 'Faces of Blue' Story Series to Raise Awareness of Colorectal Cancer Screenings Download PDF
Bausch Health Announces Participation At The J.P. Morgan Global High Yield & Leveraged Finance Conference Date 02/24/22 Title Bausch Health Announces Participation At The J.P. Morgan Global High Yield & Leveraged Finance Conference Download PDF
Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2021 Results And Provides 2022 Guidance Date 02/23/22 Title Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2021 Results And Provides 2022 Guidance Download PDF
OraPharma Launches OraFit™ Custom Clear Dental Aligner System Date 02/22/22 Title OraPharma Launches OraFit™ Custom Clear Dental Aligner System Download PDF
Salix Announces 2022 Gastrointestinal Health Scholars Program Date 02/15/22 Title Salix Announces 2022 Gastrointestinal Health Scholars Program Download PDF
Solta Medical Corporation Files Registration Statement for Proposed Initial Public Offering Date 02/08/22 Title Solta Medical Corporation Files Registration Statement for Proposed Initial Public Offering Download PDF
Bausch Health Companies Inc. Will Release Fourth-Quarter and Full-Year 2021 Financial Results on February 23 Date 02/03/22 Title Bausch Health Companies Inc. Will Release Fourth-Quarter and Full-Year 2021 Financial Results on February 23 Download PDF
BAUSCH + LOMB AND PREVENT BLINDNESS LAUNCH ANNUAL AMD AWARENESS MONTH CAMPAIGN TO EDUCATE PATIENTS Date 02/01/22 Title BAUSCH + LOMB AND PREVENT BLINDNESS LAUNCH ANNUAL AMD AWARENESS MONTH CAMPAIGN TO EDUCATE PATIENTS Download PDF
Bausch Health Announces Pricing Of Private Offering Of Senior Secured Notes Date 01/27/22 Title Bausch Health Announces Pricing Of Private Offering Of Senior Secured Notes Download PDF
Bausch Health Announces Launch Of Private Offering Of Senior Secured Notes Date 01/27/22 Title Bausch Health Announces Launch Of Private Offering Of Senior Secured Notes Download PDF
Dr. Yehia Hashad Will Join Bausch + Lomb Corporation as Executive Vice President of Research & Development and Chief Medical Officer Date 01/20/22 Title Dr. Yehia Hashad Will Join Bausch + Lomb Corporation as Executive Vice President of Research & Development and Chief Medical Officer Download PDF
Bausch Health Announces It Is Seeking To Refinance Its Existing Credit Agreement And Conditional Redemption Of Existing Notes - These Steps Will Enable Bausch + Lomb IPO And Facilitate Full Separation Date 01/18/22 Title Bausch Health Announces It Is Seeking To Refinance Its Existing Credit Agreement And Conditional Redemption Of Existing Notes - These Steps Will Enable Bausch + Lomb IPO And Facilitate Full Separation Download PDF
Bausch + Lomb Corporation Files Registration Statement and Preliminary Prospectus for Proposed Initial Public Offering Date 01/13/22 Title Bausch + Lomb Corporation Files Registration Statement and Preliminary Prospectus for Proposed Initial Public Offering Download PDF
Bausch Health Will Provide Business And Strategic Update At The 40th Annual J.P. Morgan Healthcare Conference Date 01/11/22 Title Bausch Health Will Provide Business And Strategic Update At The 40th Annual J.P. Morgan Healthcare Conference Download PDF
Bausch Health to Participate at the 40th Annual J.P. Morgan Healthcare Conference Date 01/05/22 Title Bausch Health to Participate at the 40th Annual J.P. Morgan Healthcare Conference Download PDF
New Survey from Bausch + Lomb and Glaucoma Research Foundation Reveals Emotional and Social Impact of Hyperemia on Glaucoma Patients Date 01/04/22 Title New Survey from Bausch + Lomb and Glaucoma Research Foundation Reveals Emotional and Social Impact of Hyperemia on Glaucoma Patients Download PDF
Relistor® (Methylnaltrexone Bromide) Data is Published in the Journal of Emergency Medicine Date 12/22/21 Title Relistor® (Methylnaltrexone Bromide) Data is Published in the Journal of Emergency Medicine Download PDF
APMA Grants Seal of Approval for JUBLIA® (efinaconazole) Topical Solution, 10% Date 12/06/21 Title APMA Grants Seal of Approval for JUBLIA® (efinaconazole) Topical Solution, 10% Download PDF
Salix Brings Educational Resources on Constipation Into the Homes of Patients and Caregivers for Constipation Awareness Month Date 12/03/21 Title Salix Brings Educational Resources on Constipation Into the Homes of Patients and Caregivers for Constipation Awareness Month Download PDF
Bausch + Lomb Reports More Than 41 Million Units Of Contact Lens, Eye And Lens Care Materials Recycled Through ONE By ONE And Biotrue® Eye Care Recycling Programs Date 11/15/21 Title Bausch + Lomb Reports More Than 41 Million Units Of Contact Lens, Eye And Lens Care Materials Recycled Through ONE By ONE And Biotrue® Eye Care Recycling Programs Download PDF
Salix Will Share New Rifaximin Data At AASLD's The Liver Meeting™ 2021 Date 11/11/21 Title Salix Will Share New Rifaximin Data At AASLD's The Liver Meeting™ 2021 Download PDF
Bausch Health Announces Participation In Upcoming Investor Conferences Date 11/04/21 Title Bausch Health Announces Participation In Upcoming Investor Conferences Download PDF
Bausch Health Companies Inc. Announces Third-Quarter 2021 Results Date 11/02/21 Title Bausch Health Companies Inc. Announces Third-Quarter 2021 Results Download PDF
Bausch + Lomb Will Present Scientific Data and Analyses During the American Academy of Ophthalmology and American Academy of Optometry Annual Meetings Date 11/01/21 Title Bausch + Lomb Will Present Scientific Data and Analyses During the American Academy of Ophthalmology and American Academy of Optometry Annual Meetings Download PDF
Bausch + Lomb Launches Biotrue® Eye Care Recycling Program in Collaboration With TerraCycle in the United States Date 10/27/21 Title Bausch + Lomb Launches Biotrue® Eye Care Recycling Program in Collaboration With TerraCycle in the United States Download PDF
New Report Reveals Barriers To Quality Care For Chronic Liver Disease Patients, A Cause Of Morbidity And Mortality Projected To Grow In The United States Date 10/25/21 Title New Report Reveals Barriers To Quality Care For Chronic Liver Disease Patients, A Cause Of Morbidity And Mortality Projected To Grow In The United States Download PDF
Salix Will Feature New Data At The American College Of Gastroenterology® 2021 Annual Scientific Meeting Date 10/25/21 Title Salix Will Feature New Data At The American College Of Gastroenterology® 2021 Annual Scientific Meeting Download PDF
Bausch + Lomb and Clearside Biomedical Announce FDA Approval of XIPERE™ (triamcinolone acetonide injectable suspension) for Suprachoroidal Use for the Treatment of Macular Edema Associated with Uveitis Date 10/25/21 Title Bausch + Lomb and Clearside Biomedical Announce FDA Approval of XIPERE™ (triamcinolone acetonide injectable suspension) for Suprachoroidal Use for the Treatment of Macular Edema Associated with Uveitis Download PDF
Bausch Health Announces Tom Vadaketh Will Join Bausch Pharma* As Chief Financial Officer Date 10/21/21 Title Bausch Health Announces Tom Vadaketh Will Join Bausch Pharma* As Chief Financial Officer Download PDF
Ortho Dermatologics To Present New Data At The 2021 Fall Clinical Dermatology Conference Date 10/19/21 Title Ortho Dermatologics To Present New Data At The 2021 Fall Clinical Dermatology Conference Download PDF
Bausch Health Companies Inc. Will Release Third-Quarter 2021 Financial Results On November 2 Date 10/06/21 Title Bausch Health Companies Inc. Will Release Third-Quarter 2021 Financial Results On November 2 Download PDF
Bausch + Lomb Announces Statistically Significant Topline Results from the Second Phase 3 Trial Of NOV03 (perfluorohexyloctane) in Dry Eye Disease Associated with Meibomian Gland Dysfunction Date 09/30/21 Title Bausch + Lomb Announces Statistically Significant Topline Results from the Second Phase 3 Trial Of NOV03 (perfluorohexyloctane) in Dry Eye Disease Associated with Meibomian Gland Dysfunction Download PDF
Bausch Health Releases Annual Environmental, Social and Governance Report Date 09/29/21 Title Bausch Health Releases Annual Environmental, Social and Governance Report Download PDF
Salix Will Share RELISTOR® (Methylnaltrexone Bromide) Data At PAINWeek 2021 Date 09/02/21 Title Salix Will Share RELISTOR® (Methylnaltrexone Bromide) Data At PAINWeek 2021 Download PDF
Bausch Health Announces Participation In Upcoming Investor Conferences Date 09/01/21 Title Bausch Health Announces Participation In Upcoming Investor Conferences Download PDF
Bausch Health Companies Inc. Announces Second-Quarter 2021 Results Date 08/03/21 Title Bausch Health Companies Inc. Announces Second-Quarter 2021 Results Download PDF
Bausch Health Announces Plans To Pursue An Initial Public Offering Of Solta Medical Date 08/03/21 Title Bausch Health Announces Plans To Pursue An Initial Public Offering Of Solta Medical Download PDF
Bausch Health To Reduce Debt By $350 Million Date 08/03/21 Title Bausch Health To Reduce Debt By $350 Million Download PDF
Bausch Health Completes Sale Of Amoun Pharmaceutical To ADQ Date 08/02/21 Title Bausch Health Completes Sale Of Amoun Pharmaceutical To ADQ Download PDF
Ortho Dermatologics Announces 2021 Aspire Higher Scholarship Recipients Date 07/29/21 Title Ortho Dermatologics Announces 2021 Aspire Higher Scholarship Recipients Download PDF
Salix Announces 2021 Gastrointestinal Health Scholars Program Winners Date 07/22/21 Title Salix Announces 2021 Gastrointestinal Health Scholars Program Winners Download PDF
Bausch + Lomb Will Present 14 Scientific Posters Featuring New Analyses Involving Its Surgical Technologies At The 2021 Annual Meeting Of The American Society Of Cataract And Refractive Surgery Date 07/19/21 Title Bausch + Lomb Will Present 14 Scientific Posters Featuring New Analyses Involving Its Surgical Technologies At The 2021 Annual Meeting Of The American Society Of Cataract And Refractive Surgery Download PDF
Bausch + Lomb Launches Biotrue® Hydration Boost Lubricant Eye Drops and Biotrue® Micellar Eyelid Cleansing Wipes Date 07/12/21 Title Bausch + Lomb Launches Biotrue® Hydration Boost Lubricant Eye Drops and Biotrue® Micellar Eyelid Cleansing Wipes Download PDF
Bausch + Lomb Completes Enrollment Of Second Phase 3 Study For NOV03 (perfluorohexyloctane) Date 07/07/21 Title Bausch + Lomb Completes Enrollment Of Second Phase 3 Study For NOV03 (perfluorohexyloctane) Download PDF
Bausch Health Companies Inc. Will Release Second-Quarter 2021 Financial Results On August 3 Date 07/06/21 Title Bausch Health Companies Inc. Will Release Second-Quarter 2021 Financial Results On August 3 Download PDF
Bausch Health To Reduce Debt By $150 Million Using Cash Generated From Operations Date 07/01/21 Title Bausch Health To Reduce Debt By $150 Million Using Cash Generated From Operations Download PDF
Bausch + Lomb Expands Parameters for Bausch + Lomb ULTRA® Multifocal for Astigmatism Contact Lenses Date 06/23/21 Title Bausch + Lomb Expands Parameters for Bausch + Lomb ULTRA® Multifocal for Astigmatism Contact Lenses Download PDF
Bausch Health Announces Extension Of Its Tender Offer For Cash Tender Offer For Senior Secured Notes By One Business Day To Reflect The Federal Holiday On June 18, 2021 Date 06/22/21 Title Bausch Health Announces Extension Of Its Tender Offer For Cash Tender Offer For Senior Secured Notes By One Business Day To Reflect The Federal Holiday On June 18, 2021 Download PDF
Bausch Health Announces D. Robert Hale Has Resigned From Its Board Of Directors Date 06/21/21 Title Bausch Health Announces D. Robert Hale Has Resigned From Its Board Of Directors Download PDF
Bausch + Lomb and Lochan Enter Into Agreement to Develop the Next-Generation of eyeTELLIGENCE™ Clinical Decision Support Software Date 06/08/21 Title Bausch + Lomb and Lochan Enter Into Agreement to Develop the Next-Generation of eyeTELLIGENCE™ Clinical Decision Support Software Download PDF
Bausch Health Announces Early Tender Results And Early Settlement Date For Cash Tender Offer For Senior Secured Notes Date 06/07/21 Title Bausch Health Announces Early Tender Results And Early Settlement Date For Cash Tender Offer For Senior Secured Notes Download PDF
Bausch Health And Clearside Biomedical Announce U.S. FDA Filing Acceptance For XIPERE™ (triamcinolone acetonide suprachoroidal injectable suspension) Date 06/02/21 Title Bausch Health And Clearside Biomedical Announce U.S. FDA Filing Acceptance For XIPERE™ (triamcinolone acetonide suprachoroidal injectable suspension) Download PDF
Bausch + Lomb and Prevent Blindness Launch Educational Campaign During Cataract Awareness Month Date 06/01/21 Title Bausch + Lomb and Prevent Blindness Launch Educational Campaign During Cataract Awareness Month Download PDF
Bausch Health To Reduce Debt By $100 Million Using Cash Generated From Operations Date 05/27/21 Title Bausch Health To Reduce Debt By $100 Million Using Cash Generated From Operations Download PDF
Bausch Health Announces Participation At The Jefferies Healthcare Conference Date 05/25/21 Title Bausch Health Announces Participation At The Jefferies Healthcare Conference Download PDF
Bausch Health Announces Pricing Of Private Offering Of Senior Secured Notes Date 05/24/21 Title Bausch Health Announces Pricing Of Private Offering Of Senior Secured Notes Download PDF
Bausch Health Commences Cash Tender Offer For Any And All Of Its 7.00% Senior Secured Notes Due 2024 Date 05/24/21 Title Bausch Health Commences Cash Tender Offer For Any And All Of Its 7.00% Senior Secured Notes Due 2024 Download PDF
Bausch Health Announces Launch Of Private Offering Of Senior Secured Notes And Conditional Redemption Of Existing Senior Secured Notes Date 05/24/21 Title Bausch Health Announces Launch Of Private Offering Of Senior Secured Notes And Conditional Redemption Of Existing Senior Secured Notes Download PDF
Salix Will Feature New Data At Digestive Disease Week® 2021 Date 05/17/21 Title Salix Will Feature New Data At Digestive Disease Week® 2021 Download PDF
New National Eye Institute Data Shows AREDS2 Nutrient Formula Continues To Reduce The Risk Of Moderate To Advanced Age-Related Macular Degeneration Progression Date 05/11/21 Title New National Eye Institute Data Shows AREDS2 Nutrient Formula Continues To Reduce The Risk Of Moderate To Advanced Age-Related Macular Degeneration Progression Download PDF
Bausch Health Announces Participation In Upcoming Investor Conferences Date 05/06/21 Title Bausch Health Announces Participation In Upcoming Investor Conferences Download PDF
Bausch Health Companies Inc. Announces First-Quarter 2021 Results Date 05/04/21 Title Bausch Health Companies Inc. Announces First-Quarter 2021 Results Download PDF
Bausch Health To Reduce Debt By $100 Million Using Cash Generated From Operations Date 05/03/21 Title Bausch Health To Reduce Debt By $100 Million Using Cash Generated From Operations Download PDF
Bausch + Lomb Will Present New Scientific Data And Analyses On Products And Pipeline Programs During The Association For Research In Vision And Ophthalmology Meeting Date 04/29/21 Title Bausch + Lomb Will Present New Scientific Data And Analyses On Products And Pipeline Programs During The Association For Research In Vision And Ophthalmology Meeting Download PDF
Bausch Health Announces 2021 Annual Meeting of Shareholder Results Date 04/28/21 Title Bausch Health Announces 2021 Annual Meeting of Shareholder Results Download PDF
Bausch Health Issues Form 8-K for 2021 Annual Meeting of Shareholders Presentation Date 04/27/21 Title Bausch Health Issues Form 8-K for 2021 Annual Meeting of Shareholders Presentation Download PDF
Ortho Dermatologics Announces Statistically Significant Topline Results From Second Pivotal Phase 3 Clinical Trial Evaluating IDP-126 Gel In Acne Vulgaris Date 04/22/21 Title Ortho Dermatologics Announces Statistically Significant Topline Results From Second Pivotal Phase 3 Clinical Trial Evaluating IDP-126 Gel In Acne Vulgaris Download PDF
Ortho Dermatologics to Present New Data at the AAD VMX 2021, Virtual Meeting Experience Date 04/21/21 Title Ortho Dermatologics to Present New Data at the AAD VMX 2021, Virtual Meeting Experience Download PDF
Bausch Health Announces VYZULTA® (latanoprostene bunod ophthalmic solution), 0.024%, is Now Approved In Brazil Date 04/16/21 Title Bausch Health Announces VYZULTA® (latanoprostene bunod ophthalmic solution), 0.024%, is Now Approved In Brazil Download PDF
New Report Reveals That More Than One-Third Of IBS Patients Surveyed State It Has Been More Challenging To Manage Their Symptoms During The COVID-19 Pandemic Date 04/15/21 Title New Report Reveals That More Than One-Third Of IBS Patients Surveyed State It Has Been More Challenging To Manage Their Symptoms During The COVID-19 Pandemic Download PDF
Bausch + Lomb Announces Statistically Significant Topline Results From The First Phase 3 Trial Of NOV03 (perfluorohexyloctane) In Dry Eye Disease Associated With Meibomian Gland Dysfunction Date 04/13/21 Title Bausch + Lomb Announces Statistically Significant Topline Results From The First Phase 3 Trial Of NOV03 (perfluorohexyloctane) In Dry Eye Disease Associated With Meibomian Gland Dysfunction Download PDF
Bausch Health Companies Inc. Will Release First-Quarter 2021 Financial Results On May 4 Date 04/09/21 Title Bausch Health Companies Inc. Will Release First-Quarter 2021 Financial Results On May 4 Download PDF
Bausch Health Launches ENVIVE™ Daily Probiotic Supplement Date 04/08/21 Title Bausch Health Launches ENVIVE™ Daily Probiotic Supplement Download PDF
FDA Approves Bausch + Lomb ClearVisc™ Dispersive Ophthalmic Viscosurgical Device Date 04/07/21 Title FDA Approves Bausch + Lomb ClearVisc™ Dispersive Ophthalmic Viscosurgical Device Download PDF
Bausch Health To Reduce Debt By $100 Million Using Cash Generated From Operations Date 04/07/21 Title Bausch Health To Reduce Debt By $100 Million Using Cash Generated From Operations Download PDF
Bausch Health Agrees To Sell Amoun Pharmaceuticals Date 03/31/21 Title Bausch Health Agrees To Sell Amoun Pharmaceuticals Download PDF
Salix Launches GastroHub for Advanced Practice Providers, an Educational Website Designed To Provide Nurse Practitioners and Physician Assistants With Relevant Information for Treating IBS-D and HE Date 03/30/21 Title Salix Launches GastroHub for Advanced Practice Providers, an Educational Website Designed To Provide Nurse Practitioners and Physician Assistants With Relevant Information for Treating IBS-D and HE Download PDF
Bausch Health Announces CFO Succession Plan Date 03/11/21 Title Bausch Health Announces CFO Succession Plan Download PDF
Bausch Health Publishes Pipeline Update For The Barclays Global Healthcare Conference Date 03/09/21 Title Bausch Health Publishes Pipeline Update For The Barclays Global Healthcare Conference Download PDF
Solta Medical Announces the U.S. Launch of The Clear + Brilliant® Touch Laser Date 03/08/21 Title Solta Medical Announces the U.S. Launch of The Clear + Brilliant® Touch Laser Download PDF
Colon Cancer Coalition and Salix to Launch a Year-Long Campaign to Raise Awareness About the Importance of Colorectal Cancer Screenings Date 03/01/21 Title Colon Cancer Coalition and Salix to Launch a Year-Long Campaign to Raise Awareness About the Importance of Colorectal Cancer Screenings Download PDF
Bausch Health To Reduce Debt By $100 Million Using Cash Generated From Operations Date 02/26/21 Title Bausch Health To Reduce Debt By $100 Million Using Cash Generated From Operations Download PDF
Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2020 Results And Provides 2021 Guidance Date 02/24/21 Title Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2020 Results And Provides 2021 Guidance Download PDF
Bausch Health Announces Agreement With Carl C. Icahn Date 02/24/21 Title Bausch Health Announces Agreement With Carl C. Icahn Download PDF
Bausch + Lomb Launches Alaway® Preservative Free Antihistamine Eye Drops Date 02/23/21 Title Bausch + Lomb Launches Alaway® Preservative Free Antihistamine Eye Drops Download PDF
Bausch Health To Reduce Debt By $100 Million Using Cash Generated From Operations Date 02/22/21 Title Bausch Health To Reduce Debt By $100 Million Using Cash Generated From Operations Download PDF
Salix Announces 2021 Gastrointestinal Health Scholars Program Date 02/18/21 Title Salix Announces 2021 Gastrointestinal Health Scholars Program Download PDF
Bausch Health Announces Participation In Upcoming Investor Conferences Date 02/16/21 Title Bausch Health Announces Participation In Upcoming Investor Conferences Download PDF
Bausch Health Responds To Schedule 13D Filing From Icahn Capital LP Date 02/11/21 Title Bausch Health Responds To Schedule 13D Filing From Icahn Capital LP Download PDF
Bausch Health Announces VYZULTA® (latanoprostene bunod ophthalmic solution), 0.024%, is Now Approved in South Korea Date 02/09/21 Title Bausch Health Announces VYZULTA® (latanoprostene bunod ophthalmic solution), 0.024%, is Now Approved in South Korea Download PDF
Ortho Dermatologics Announces 2021 Aspire Higher Scholarship Program Date 02/02/21 Title Ortho Dermatologics Announces 2021 Aspire Higher Scholarship Program Download PDF
Prevent Blindness and Bausch + Lomb to Launch Year-Long Video Series to Raise Awareness of Age-Related Macular Degeneration (AMD) Date 02/01/21 Title Prevent Blindness and Bausch + Lomb to Launch Year-Long Video Series to Raise Awareness of Age-Related Macular Degeneration (AMD) Download PDF
Bausch Health Companies Inc. Will Release Fourth-Quarter And Full-Year 2020 Financial Results On February 24 Date 01/27/21 Title Bausch Health Companies Inc. Will Release Fourth-Quarter And Full-Year 2020 Financial Results On February 24 Download PDF
South Korea's MFDS Approves LUMIFY® Eye Drops Date 01/21/21 Title South Korea's MFDS Approves LUMIFY® Eye Drops Download PDF
Bausch + Lomb Announces Scientific Data On Bausch + Lomb INFUSE™ Silicone Hydrogel Daily Disposable Contact Lenses To Be Presented At The Virtual Global Specialty Lens Symposium Date 01/20/21 Title Bausch + Lomb Announces Scientific Data On Bausch + Lomb INFUSE™ Silicone Hydrogel Daily Disposable Contact Lenses To Be Presented At The Virtual Global Specialty Lens Symposium Download PDF
Bausch + Lomb Completes Enrollment Of First Phase 3 Study For NOV03 (perfluorohexyloctane) Date 01/19/21 Title Bausch + Lomb Completes Enrollment Of First Phase 3 Study For NOV03 (perfluorohexyloctane) Download PDF
Bausch Health Provides Preliminary Update On Fourth-Quarter And Full-Year 2020 Financial Results And Business Recovery Date 01/12/21 Title Bausch Health Provides Preliminary Update On Fourth-Quarter And Full-Year 2020 Financial Results And Business Recovery Download PDF
Bausch Health To Participate At The 39th Annual J.P. Morgan Healthcare Conference Date 01/06/21 Title Bausch Health To Participate At The 39th Annual J.P. Morgan Healthcare Conference Download PDF
Bausch Health's DEXAVEN (Dexamethasone Phosphate) Receives New Indication In Poland To Treat Patients With SARS-CoV-2 (COVID-19) Date 12/30/20 Title Bausch Health's DEXAVEN (Dexamethasone Phosphate) Receives New Indication In Poland To Treat Patients With SARS-CoV-2 (COVID-19) Download PDF
Bausch Health To Reduce Debt By $275 Million Date 12/29/20 Title Bausch Health To Reduce Debt By $275 Million Download PDF
Bausch Health Initiates Second Phase 3 Study For NOV03 Investigational Treatment For Dry Eye Disease Associated With Meibomian Gland Dysfunction Date 11/24/20 Title Bausch Health Initiates Second Phase 3 Study For NOV03 Investigational Treatment For Dry Eye Disease Associated With Meibomian Gland Dysfunction Download PDF
Bausch Health Announces Pricing And Upsize Of Private Offering Of Senior Notes And Conditional Redemption Of Additional Series Of Existing Senior Notes Date 11/18/20 Title Bausch Health Announces Pricing And Upsize Of Private Offering Of Senior Notes And Conditional Redemption Of Additional Series Of Existing Senior Notes Download PDF
Bausch Health Announces Launch Of Private Offering Of Senior Notes And Conditional Redemption Of Existing Senior Notes Date 11/18/20 Title Bausch Health Announces Launch Of Private Offering Of Senior Notes And Conditional Redemption Of Existing Senior Notes Download PDF
Bausch Health Announces Investigational In Vitro Data Indicating Complete Inactivation Of SARS-CoV-2 With LUMIFY® And BESIVANCE® Eye Drops Preserved With Benzalkonium Chloride Date 11/16/20 Title Bausch Health Announces Investigational In Vitro Data Indicating Complete Inactivation Of SARS-CoV-2 With LUMIFY® And BESIVANCE® Eye Drops Preserved With Benzalkonium Chloride Download PDF
Bausch + Lomb Reports Nearly 27 Million Units of Contact Lens Materials Recycled Through One By One Recycling Program Date 11/12/20 Title Bausch + Lomb Reports Nearly 27 Million Units of Contact Lens Materials Recycled Through One By One Recycling Program Download PDF
Salix To Present Data At AASLD's The Liver Meeting Digital Experience Date 11/11/20 Title Salix To Present Data At AASLD's The Liver Meeting Digital Experience Download PDF
Bausch Health Announces Participation In Upcoming Investor Conferences Date 11/10/20 Title Bausch Health Announces Participation In Upcoming Investor Conferences Download PDF
Bausch Health Companies Inc. Announces Third-Quarter 2020 Results Date 11/03/20 Title Bausch Health Companies Inc. Announces Third-Quarter 2020 Results Download PDF
Bausch Health's Rifaximin Receives FDA Orphan Designation For Sickle Cell Disease Date 10/29/20 Title Bausch Health's Rifaximin Receives FDA Orphan Designation For Sickle Cell Disease Download PDF
Bausch Health To Reduce Debt By $150 Million Using Cash Generated From Operations Date 10/29/20 Title Bausch Health To Reduce Debt By $150 Million Using Cash Generated From Operations Download PDF
Bausch + Lomb Introduces SimplifEYE™ IOL Delivery System For enVista® Toric And Monofocal Preloaded Intraocular Lenses Date 10/27/20 Title Bausch + Lomb Introduces SimplifEYE™ IOL Delivery System For enVista® Toric And Monofocal Preloaded Intraocular Lenses Download PDF
Ortho Dermatologics To Present New Analyses At The Virtual Fall Clinical Dermatology Conference Date 10/26/20 Title Ortho Dermatologics To Present New Analyses At The Virtual Fall Clinical Dermatology Conference Download PDF
Salix To Present Data For Products Across Its Portfolio At The American College Of Gastroenterology 2020 Virtual Annual Meeting Date 10/22/20 Title Salix To Present Data For Products Across Its Portfolio At The American College Of Gastroenterology 2020 Virtual Annual Meeting Download PDF
Bausch Health And BHVI Announce Exclusive Global Licensing Agreement For Myopia Control Contact Lens Date 10/15/20 Title Bausch Health And BHVI Announce Exclusive Global Licensing Agreement For Myopia Control Contact Lens Download PDF
Bausch Health Licenses Eyenovia's Investigational Treatment For The Reduction Of Pediatric Myopia Progression In Children Ages 3-12 Date 10/12/20 Title Bausch Health Licenses Eyenovia's Investigational Treatment For The Reduction Of Pediatric Myopia Progression In Children Ages 3-12 Download PDF
Salix To Present Clinical Data At United European Gastroenterology Week Virtual 2020 Date 10/08/20 Title Salix To Present Clinical Data At United European Gastroenterology Week Virtual 2020 Download PDF
Bausch Health Companies Inc. Provides Preliminary Update On Third-Quarter 2020 Financial Results And Business Recovery Date 10/08/20 Title Bausch Health Companies Inc. Provides Preliminary Update On Third-Quarter 2020 Financial Results And Business Recovery Download PDF
Bausch + Lomb Announces New Scientific And Clinical Analyses To Be Presented On Bausch + Lomb Infuse™ Silicone Hydrogel Daily Disposable Contact Lenses During The American Academy Of Optometry Annual Meeting Date 10/06/20 Title Bausch + Lomb Announces New Scientific And Clinical Analyses To Be Presented On Bausch + Lomb Infuse™ Silicone Hydrogel Daily Disposable Contact Lenses During The American Academy Of Optometry Annual Meeting Download PDF
Salix Supports Liver Awareness Month With New Educational Initiatives Date 10/05/20 Title Salix Supports Liver Awareness Month With New Educational Initiatives Download PDF
Nielsen's BASES Names LUMIFY® Eye Drops To 2020 U.S. BASES Top 25 Breakthrough Innovations List Date 10/01/20 Title Nielsen's BASES Names LUMIFY® Eye Drops To 2020 U.S. BASES Top 25 Breakthrough Innovations List Download PDF
FDA Approves Bausch + Lomb Alaway® Preservative Free (Ketotifen Fumarate) Ophthalmic Solution, 0.035% Date 09/25/20 Title FDA Approves Bausch + Lomb Alaway® Preservative Free (Ketotifen Fumarate) Ophthalmic Solution, 0.035% Download PDF
Bausch Health Announces VYZULTA® (Latanoprostene Bunod Ophthalmic Solution), 0.024%, is Now Approved In Seven Countries Date 09/24/20 Title Bausch Health Announces VYZULTA® (Latanoprostene Bunod Ophthalmic Solution), 0.024%, is Now Approved In Seven Countries Download PDF
Bausch Health Releases Annual Corporate Social Responsibility Report Date 09/23/20 Title Bausch Health Releases Annual Corporate Social Responsibility Report Download PDF
Bausch Health And Alfasigma Announce Resolution Of XIFAXAN® Intellectual Property Litigation Date 09/22/20 Title Bausch Health And Alfasigma Announce Resolution Of XIFAXAN® Intellectual Property Litigation Download PDF
Bausch Health To Acquire Option To Purchase All Ophthalmology Assets Of Allegro Ophthalmics Date 09/21/20 Title Bausch Health To Acquire Option To Purchase All Ophthalmology Assets Of Allegro Ophthalmics Download PDF
Bausch Health Provides Company Update At 18th Annual Morgan Stanley Global Healthcare Conference Date 09/16/20 Title Bausch Health Provides Company Update At 18th Annual Morgan Stanley Global Healthcare Conference Download PDF
Bausch Foundation Releases Inaugural Activity Report Date 09/10/20 Title Bausch Foundation Releases Inaugural Activity Report Download PDF
Bausch Health To Participate At The 18th Annual Morgan Stanley Global Healthcare Conference Date 09/09/20 Title Bausch Health To Participate At The 18th Annual Morgan Stanley Global Healthcare Conference Download PDF
Bausch Health To Reduce Debt By $100 Million Using Cash Generated From Operations Date 08/31/20 Title Bausch Health To Reduce Debt By $100 Million Using Cash Generated From Operations Download PDF
Australia's TGA Approves BAUSCH + LOMB ULTRA® ONE DAY Silicone Hydrogel Daily Disposable Contact Lenses Date 08/18/20 Title Australia's TGA Approves BAUSCH + LOMB ULTRA® ONE DAY Silicone Hydrogel Daily Disposable Contact Lenses Download PDF
Bausch + Lomb Launches Innovative Bausch + Lomb INFUSE™ Silicone Hydrogel (SiHy) Daily Disposable Contact Lenses Date 08/17/20 Title Bausch + Lomb Launches Innovative Bausch + Lomb INFUSE™ Silicone Hydrogel (SiHy) Daily Disposable Contact Lenses Download PDF
Health Canada Approves BAUSCH + LOMB ULTRA ONE DAY® Silicone Hydrogel Daily Disposable Contact Lenses Date 08/11/20 Title Health Canada Approves BAUSCH + LOMB ULTRA ONE DAY® Silicone Hydrogel Daily Disposable Contact Lenses Download PDF
Bausch Health Announces Its Intention To Spin Off Its Eye Health Business Into An Independent Publicly Traded Company Date 08/06/20 Title Bausch Health Announces Its Intention To Spin Off Its Eye Health Business Into An Independent Publicly Traded Company Download PDF
Bausch Health Companies Inc. Announces Second-Quarter 2020 Results Date 08/06/20 Title Bausch Health Companies Inc. Announces Second-Quarter 2020 Results Download PDF
Bausch Health Resolves Canadian Securities Class Action Date 08/05/20 Title Bausch Health Resolves Canadian Securities Class Action Download PDF
Bausch Health Resolves Legacy SEC Investigation Date 07/31/20 Title Bausch Health Resolves Legacy SEC Investigation Download PDF
Ortho Dermatologics Announces 2020 Aspire Higher Scholarship Recipients Date 07/28/20 Title Ortho Dermatologics Announces 2020 Aspire Higher Scholarship Recipients Download PDF
Bausch Health Companies Inc. Will Release Second-Quarter 2020 Financial Results On August 6 Date 07/23/20 Title Bausch Health Companies Inc. Will Release Second-Quarter 2020 Financial Results On August 6 Download PDF
Ortho Dermatologics Launches ARAZLO™ (tazarotene) Lotion, 0.045%, In The United States Date 06/23/20 Title Ortho Dermatologics Launches ARAZLO™ (tazarotene) Lotion, 0.045%, In The United States Download PDF
BAUSCH + LOMB ULTRA® Silicone Hydrogel Contact Lenses Receive Approval In China Date 06/17/20 Title BAUSCH + LOMB ULTRA® Silicone Hydrogel Contact Lenses Receive Approval In China Download PDF
Bausch Health to Participate at Goldman Sachs Annual Leveraged Finance Conference Date 06/16/20 Title Bausch Health to Participate at Goldman Sachs Annual Leveraged Finance Conference Download PDF
Salix Announces Inaugural Salix Gastrointestinal Health Scholars Program Recipients Date 06/15/20 Title Salix Announces Inaugural Salix Gastrointestinal Health Scholars Program Recipients Download PDF
FDA Provides 510(k) Clearance For BAUSCH + LOMB INFUSE™ Daily Disposable Silicone Hydrogel (SiHy Daily) Contact Lenses Date 06/04/20 Title FDA Provides 510(k) Clearance For BAUSCH + LOMB INFUSE™ Daily Disposable Silicone Hydrogel (SiHy Daily) Contact Lenses Download PDF
Bausch + Lomb Announces The European Launch Of LuxSmart™ And LuxGood™ Preloaded Intraocular Lenses Date 05/27/20 Title Bausch + Lomb Announces The European Launch Of LuxSmart™ And LuxGood™ Preloaded Intraocular Lenses Download PDF
Bausch Health To Participate At Goldman Sachs Annual Global Healthcare Conference Date 05/21/20 Title Bausch Health To Participate At Goldman Sachs Annual Global Healthcare Conference Download PDF
Bausch Health Announces Pricing And Upsize Of Private Offering Of Senior Notes And Prepayment Of Term Loan 2022 Mandatory Amortization Date 05/11/20 Title Bausch Health Announces Pricing And Upsize Of Private Offering Of Senior Notes And Prepayment Of Term Loan 2022 Mandatory Amortization Download PDF
Bausch Health Announces Launch of Private Offering of Senior Notes and Conditional Redemption of Existing Senior Secured Notes Date 05/11/20 Title Bausch Health Announces Launch of Private Offering of Senior Notes and Conditional Redemption of Existing Senior Secured Notes Download PDF
Bausch Health Companies Inc. Announces First-Quarter 2020 Results Date 05/07/20 Title Bausch Health Companies Inc. Announces First-Quarter 2020 Results Download PDF
Bausch Health And Alfasigma Announce Resolution Of XIFAXAN® Intellectual Property Litigation Date 05/06/20 Title Bausch Health And Alfasigma Announce Resolution Of XIFAXAN® Intellectual Property Litigation Download PDF
Bausch Health To Participate at 2020 Bank of America Merrill Lynch Global Healthcare Conference Date 04/30/20 Title Bausch Health To Participate at 2020 Bank of America Merrill Lynch Global Healthcare Conference Download PDF
Salix To Highlight New Data Across Its Portfolio Of Products At Digestive Disease Week 2020 Virtual Meeting Date 04/30/20 Title Salix To Highlight New Data Across Its Portfolio Of Products At Digestive Disease Week 2020 Virtual Meeting Download PDF
Bausch Health Announces 2020 Annual Meeting Of Shareholder Results Date 04/29/20 Title Bausch Health Announces 2020 Annual Meeting Of Shareholder Results Download PDF
FDA Approves Ortho Dermatologics' Labeling For JUBLIA® (efinaconazole) Topical Solution, 10%, In Patients As Young As Six Years Old Date 04/29/20 Title FDA Approves Ortho Dermatologics' Labeling For JUBLIA® (efinaconazole) Topical Solution, 10%, In Patients As Young As Six Years Old Download PDF
Bausch Health Issues Form 8-K For 2020 Annual Meeting Of Shareholders Presentation Date 04/28/20 Title Bausch Health Issues Form 8-K For 2020 Annual Meeting Of Shareholders Presentation Download PDF
Bausch Health Companies Inc. Will Release First-Quarter 2020 Financial Results On May 7 Date 04/23/20 Title Bausch Health Companies Inc. Will Release First-Quarter 2020 Financial Results On May 7 Download PDF
Bausch + Lomb Announces Publication Of 10-Year Armor Study Results On Ocular Antibiotic Resistance In JAMA Ophthalmology Date 04/14/20 Title Bausch + Lomb Announces Publication Of 10-Year Armor Study Results On Ocular Antibiotic Resistance In JAMA Ophthalmology Download PDF
Bausch Health Initiates VIRAZOLE® (Ribavirin for Inhalation Solution, USP) Clinical Study in Patients with COVID-19 Date 04/13/20 Title Bausch Health Initiates VIRAZOLE® (Ribavirin for Inhalation Solution, USP) Clinical Study in Patients with COVID-19 Download PDF
Bausch Health Companies Inc. Will Hold Virtual Annual Meeting Of Shareholders On April 28 Date 04/02/20 Title Bausch Health Companies Inc. Will Hold Virtual Annual Meeting Of Shareholders On April 28 Download PDF
Bausch Health Announces Favorable Topline Results From Study Evaluating Investigative Formulation of Rifaximin SSD IR to Treat Overt Hepatic Encephalopathy Date 03/31/20 Title Bausch Health Announces Favorable Topline Results From Study Evaluating Investigative Formulation of Rifaximin SSD IR to Treat Overt Hepatic Encephalopathy Download PDF
Bausch Health Donates Health Care Products And Supplies Through Bausch Foundation In Response To COVID-19 Pandemic Date 03/24/20 Title Bausch Health Donates Health Care Products And Supplies Through Bausch Foundation In Response To COVID-19 Pandemic Download PDF
Bausch Health To Reduce Debt By Approximately $100 Million Using Cash Generated From Operations Date 03/13/20 Title Bausch Health To Reduce Debt By Approximately $100 Million Using Cash Generated From Operations Download PDF
Bausch Health Announces It Will No Longer Pursue Proposed Refinancing Transaction And Also Announces Cancellation Of Previously Delivered Notice Of Conditional Redemption Date 03/02/20 Title Bausch Health Announces It Will No Longer Pursue Proposed Refinancing Transaction And Also Announces Cancellation Of Previously Delivered Notice Of Conditional Redemption Download PDF
Bausch Health Announces It Is Seeking A Refinancing Amendment To Its Existing Credit Agreement And Conditional Redemption Of Existing Senior Secured Notes Date 02/19/20 Title Bausch Health Announces It Is Seeking A Refinancing Amendment To Its Existing Credit Agreement And Conditional Redemption Of Existing Senior Secured Notes Download PDF
Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2019 Results And Provides 2020 Guidance Date 02/19/20 Title Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2019 Results And Provides 2020 Guidance Download PDF
Ortho Dermatologics Launches Telemedicine on Dermatology.com, U.S. Cash-Pay Prescription Program Date 02/18/20 Title Ortho Dermatologics Launches Telemedicine on Dermatology.com, U.S. Cash-Pay Prescription Program Download PDF
Bausch Health To Reduce Debt By $100 Million Using Cash Generated From Operations Date 02/12/20 Title Bausch Health To Reduce Debt By $100 Million Using Cash Generated From Operations Download PDF
Bausch Health Announces Participation In Upcoming Investor Conferences Date 02/04/20 Title Bausch Health Announces Participation In Upcoming Investor Conferences Download PDF
Bausch + Lomb And Prevent Blindness Join Together To Raise Awareness And Provide Educational Resources For February's Age-Related Macular Degeneration Awareness Month Date 02/03/20 Title Bausch + Lomb And Prevent Blindness Join Together To Raise Awareness And Provide Educational Resources For February's Age-Related Macular Degeneration Awareness Month Download PDF
Ortho Dermatologics Opens 2020 Aspire Higher Scholarship Program Date 02/03/20 Title Ortho Dermatologics Opens 2020 Aspire Higher Scholarship Program Download PDF
Bausch Health and Clearside Biomedical Announce Publication of PIVOTAL Phase 3 Data ON XIPERETM (triamcinolone acetonide suprachoroidal injectable suspension) in Ophthalmology Date 01/28/20 Title Bausch Health and Clearside Biomedical Announce Publication of PIVOTAL Phase 3 Data ON XIPERETM (triamcinolone acetonide suprachoroidal injectable suspension) in Ophthalmology Download PDF
Bausch Health Companies Inc. Will Release Fourth-Quarter and Full-Year 2019 Financial Results on February 19 Date 01/16/20 Title Bausch Health Companies Inc. Will Release Fourth-Quarter and Full-Year 2019 Financial Results on February 19 Download PDF
Bausch Health Publishes Company Update for the 38th Annual J.P. Morgan Healthcare Conference Date 01/13/20 Title Bausch Health Publishes Company Update for the 38th Annual J.P. Morgan Healthcare Conference Download PDF
Ortho Dermatologics Announces Publication Of Pivotal Phase 3 Data On ARAZLO™ (tazarotene) Lotion, 0.045% In The Journal Of Drugs In Dermatology (JDD) Date 01/13/20 Title Ortho Dermatologics Announces Publication Of Pivotal Phase 3 Data On ARAZLO™ (tazarotene) Lotion, 0.045% In The Journal Of Drugs In Dermatology (JDD) Download PDF
Bausch + Lomb Launches Expanded Parameters for Biotrue® ONEday for Astigmatism Daily Disposable Contact Lenses Date 01/06/20 Title Bausch + Lomb Launches Expanded Parameters for Biotrue® ONEday for Astigmatism Daily Disposable Contact Lenses Download PDF
Bausch Health To Participate At The 38th Annual J.P. Morgan Healthcare Conference Date 01/06/20 Title Bausch Health To Participate At The 38th Annual J.P. Morgan Healthcare Conference Download PDF
Bausch Health Licenses Novaliq's NOV03 Investigational Treatment For Dry Eye Disease Associated With Meibomian Gland Dysfunction Date 12/20/19 Title Bausch Health Licenses Novaliq's NOV03 Investigational Treatment For Dry Eye Disease Associated With Meibomian Gland Dysfunction Download PDF
Bausch Health Announces Resolution Of BRYHALI® (Halobetasol Propionate) Lotion, 0.01%, Intellectual Property Litigation With Glenmark Date 12/20/19 Title Bausch Health Announces Resolution Of BRYHALI® (Halobetasol Propionate) Lotion, 0.01%, Intellectual Property Litigation With Glenmark Download PDF
FDA Approves Ortho Dermatologics' ARAZLOTM (Tazarotene) Lotion, 0.045%, For Acne Vulgaris Date 12/19/19 Title FDA Approves Ortho Dermatologics' ARAZLOTM (Tazarotene) Lotion, 0.045%, For Acne Vulgaris Download PDF
Bausch Health Announces Conditional Redemption Of Existing Senior Notes Date 12/18/19 Title Bausch Health Announces Conditional Redemption Of Existing Senior Notes Download PDF
Bausch Health Announces Pricing of Private Offering of Senior Notes Date 12/17/19 Title Bausch Health Announces Pricing of Private Offering of Senior Notes Download PDF
Bausch + Lomb Initiates Clinical Trial Evaluating New Cohesive Ophthalmic Viscosurgical Device (OVD) For Use In Cataract Surgery Date 12/17/19 Title Bausch + Lomb Initiates Clinical Trial Evaluating New Cohesive Ophthalmic Viscosurgical Device (OVD) For Use In Cataract Surgery Download PDF
Bausch Health Announces Launch Of Private Offering Of Senior Notes Date 12/17/19 Title Bausch Health Announces Launch Of Private Offering Of Senior Notes Download PDF
Bausch Health Resolves "Stock Drop" Litigation Initially Filed in October 2015 Date 12/16/19 Title Bausch Health Resolves "Stock Drop" Litigation Initially Filed in October 2015 Download PDF
Bausch + Lomb Introduces enVista® Toric MX60ET Intraocular Lens With StableFlex™ Technology Date 12/11/19 Title Bausch + Lomb Introduces enVista® Toric MX60ET Intraocular Lens With StableFlex™ Technology Download PDF
Bausch + Lomb And TerraCycle Announce Donation Of New Custom Training Modules Incorporating Used Contact Lens Materials To Guide Dog Foundation Date 11/13/19 Title Bausch + Lomb And TerraCycle Announce Donation Of New Custom Training Modules Incorporating Used Contact Lens Materials To Guide Dog Foundation Download PDF
Bausch Health Companies Announces Participation in Upcoming Investor Conferences Date 11/11/19 Title Bausch Health Companies Announces Participation in Upcoming Investor Conferences Download PDF
Bausch Health Companies Inc. Announces Third-Quarter 2019 Results and Raises Full-Year Revenue and Adjusted EBITDA (non-GAAP) Guidance Ranges Date 11/04/19 Title Bausch Health Companies Inc. Announces Third-Quarter 2019 Results and Raises Full-Year Revenue and Adjusted EBITDA (non-GAAP) Guidance Ranges Download PDF
Salix Announces Issuance of an Additional XIFAXAN® Patent Date 10/31/19 Title Salix Announces Issuance of an Additional XIFAXAN® Patent Download PDF
Salix Pharmaceuticals Announces Inaugural Scholarship Program To Commemorate Its 30th Anniversary Date 10/30/19 Title Salix Pharmaceuticals Announces Inaugural Scholarship Program To Commemorate Its 30th Anniversary Download PDF
Salix Pharmaceuticals to Present New Clinical Data at the American College of Gastroenterology (ACG) Annual Meeting Date 10/28/19 Title Salix Pharmaceuticals to Present New Clinical Data at the American College of Gastroenterology (ACG) Annual Meeting Download PDF
Bausch Health Licenses Clearside Biomedical's XIPERE™ (Triamcinolone Acetonide Suprachoroidal Injectable Suspension), An Investigational Treatment For Macular Edema Associated With Uveitis Date 10/23/19 Title Bausch Health Licenses Clearside Biomedical's XIPERE™ (Triamcinolone Acetonide Suprachoroidal Injectable Suspension), An Investigational Treatment For Macular Edema Associated With Uveitis Download PDF
Bausch + Lomb Introduces PreserVision® AREDS 2 Formula Minigel Eye Vitamins Date 10/21/19 Title Bausch + Lomb Introduces PreserVision® AREDS 2 Formula Minigel Eye Vitamins Download PDF
Bausch Health's Ortho Dermatologics Business To Present Data At The Fall Clinical Dermatology Conference Date 10/15/19 Title Bausch Health's Ortho Dermatologics Business To Present Data At The Fall Clinical Dermatology Conference Download PDF
Ortho Dermatologics Announces 2019 Aspire Higher Scholarship Recipients Date 10/10/19 Title Ortho Dermatologics Announces 2019 Aspire Higher Scholarship Recipients Download PDF
Bausch + Lomb Announces New Scientific And Clinical Analyses To Be Presented During The American Academy Of Ophthalmology And American Academy Of Optometry Annual Meetings Date 10/07/19 Title Bausch + Lomb Announces New Scientific And Clinical Analyses To Be Presented During The American Academy Of Ophthalmology And American Academy Of Optometry Annual Meetings Download PDF
Bausch Health Companies Inc. Will Release Third-Quarter 2019 Financial Results on November 4 Date 10/04/19 Title Bausch Health Companies Inc. Will Release Third-Quarter 2019 Financial Results on November 4 Download PDF
Bausch Health Files Lawsuit Against Sandoz For Infringement Of Patents Protecting XIFAXAN® 550 mg Tablets Date 10/01/19 Title Bausch Health Files Lawsuit Against Sandoz For Infringement Of Patents Protecting XIFAXAN® 550 mg Tablets Download PDF
Bausch Health Releases 2018 Corporate Social Responsibility Report Date 09/10/19 Title Bausch Health Releases 2018 Corporate Social Responsibility Report Download PDF
Bausch Health To Reduce Debt By Approximately $200 Million Using Cash Flow From Operations Date 09/03/19 Title Bausch Health To Reduce Debt By Approximately $200 Million Using Cash Flow From Operations Download PDF
Bausch Health Companies Announces Participation In Upcoming Investor Conferences Date 08/29/19 Title Bausch Health Companies Announces Participation In Upcoming Investor Conferences Download PDF
Ortho Dermatologics Announces U.S. FDA Filing Acceptance For IDP-123 Treatment For Acne Vulgaris In Lotion Form Date 08/07/19 Title Ortho Dermatologics Announces U.S. FDA Filing Acceptance For IDP-123 Treatment For Acne Vulgaris In Lotion Form Download PDF
Bausch Health Companies Inc. Announces Second-Quarter 2019 Results And Raises Full-Year Guidance Date 08/06/19 Title Bausch Health Companies Inc. Announces Second-Quarter 2019 Results And Raises Full-Year Guidance Download PDF
Bausch Health Expands Dermatology Cash-Pay Prescription Program to Walgreens Stores Nationwide Date 08/01/19 Title Bausch Health Expands Dermatology Cash-Pay Prescription Program to Walgreens Stores Nationwide Download PDF
Bausch Health Provides APRISO® Intellectual Property Litigation Update Date 07/31/19 Title Bausch Health Provides APRISO® Intellectual Property Litigation Update Download PDF
Bausch Health to Reduce Debt by Additional $100 Million Using Cash Flow from Operations Date 07/29/19 Title Bausch Health to Reduce Debt by Additional $100 Million Using Cash Flow from Operations Download PDF
Court Upholds The Validity And Determined Actavis' Infringement Of Patent Protecting RELISTOR® Tablets Date 07/17/19 Title Court Upholds The Validity And Determined Actavis' Infringement Of Patent Protecting RELISTOR® Tablets Download PDF
Bausch + Lomb Announces U.S. Launch Of Ocuvite® Eye Performance Vitamins Date 07/09/19 Title Bausch + Lomb Announces U.S. Launch Of Ocuvite® Eye Performance Vitamins Download PDF
Bausch Health Companies Inc. Will Release Second-Quarter 2019 Financial Results On August 6 Date 07/08/19 Title Bausch Health Companies Inc. Will Release Second-Quarter 2019 Financial Results On August 6 Download PDF
Bausch Health To Reduce Debt By Additional $100 Million Using Cash Generated From Operations Date 06/25/19 Title Bausch Health To Reduce Debt By Additional $100 Million Using Cash Generated From Operations Download PDF
Bausch Health Announces U.S. Launch of DUOBRII™ (halobetasol propionate and tazarotene) Lotion 0.01%/0.045% for Plaque Psoriasis in Adults Date 06/25/19 Title Bausch Health Announces U.S. Launch of DUOBRII™ (halobetasol propionate and tazarotene) Lotion 0.01%/0.045% for Plaque Psoriasis in Adults Download PDF
Bausch + Lomb ULTRA® Multifocal for Astigmatism Contact Lenses Now Available In the United States Date 06/19/19 Title Bausch + Lomb ULTRA® Multifocal for Astigmatism Contact Lenses Now Available In the United States Download PDF
Bausch Health Companies Announces Participation in Upcoming Investor Conferences Date 05/29/19 Title Bausch Health Companies Announces Participation in Upcoming Investor Conferences Download PDF
Bausch Health Announces Early Tender Results and Early Settlement Date for Cash Tender Offers for Senior Notes Date 05/23/19 Title Bausch Health Announces Early Tender Results and Early Settlement Date for Cash Tender Offers for Senior Notes Download PDF
Bausch Health Announces Pricing Of Private Offering Of Senior Notes Date 05/09/19 Title Bausch Health Announces Pricing Of Private Offering Of Senior Notes Download PDF
Bausch Health Commences Cash Tender Offers For Up To $1,500,000,000 Aggregate Principal Amount Of Outstanding Notes Of Certain Series Date 05/09/19 Title Bausch Health Commences Cash Tender Offers For Up To $1,500,000,000 Aggregate Principal Amount Of Outstanding Notes Of Certain Series Download PDF
Bausch Health Announces Launch Of Private Offering Of Senior Notes Date 05/09/19 Title Bausch Health Announces Launch Of Private Offering Of Senior Notes Download PDF
Bausch Health Companies Inc. Announces First-Quarter 2019 Results And Raises Full-Year Guidance Date 05/06/19 Title Bausch Health Companies Inc. Announces First-Quarter 2019 Results And Raises Full-Year Guidance Download PDF
Bausch Health Issues Form 8K For 2019 Annual Meeting Of Shareholders Presentation Date 04/30/19 Title Bausch Health Issues Form 8K For 2019 Annual Meeting Of Shareholders Presentation Download PDF
Bausch + Lomb Announces New Scientific Analyses Featuring Surgical And Pharmaceutical Products Will Be Presented During The Annual Meeting Of The American Society Of Cataract And Refractive Surgery Date 04/29/19 Title Bausch + Lomb Announces New Scientific Analyses Featuring Surgical And Pharmaceutical Products Will Be Presented During The Annual Meeting Of The American Society Of Cataract And Refractive Surgery Download PDF
New Scientific And Clinical Analyses Regarding Bausch + Lomb Surgical And Pharmaceutical Products To Be Presented During The Association For Research In Vision And Ophthalmology Meeting Date 04/26/19 Title New Scientific And Clinical Analyses Regarding Bausch + Lomb Surgical And Pharmaceutical Products To Be Presented During The Association For Research In Vision And Ophthalmology Meeting Download PDF
FDA Approves Bausch Health's DUOBRII™ (Halobetasol Propionate And Tazarotene) Lotion 0.01%/0.045% For Plaque Psoriasis In Adults Date 04/25/19 Title FDA Approves Bausch Health's DUOBRII™ (Halobetasol Propionate And Tazarotene) Lotion 0.01%/0.045% For Plaque Psoriasis In Adults Download PDF
Salix Enters Into Exclusive License Agreement With Mitsubishi Tanabe Pharma To Develop And Commercialize Late Stage Investigational S1P Modulator For The Treatment Of Inflammatory Bowel Disease Date 04/25/19 Title Salix Enters Into Exclusive License Agreement With Mitsubishi Tanabe Pharma To Develop And Commercialize Late Stage Investigational S1P Modulator For The Treatment Of Inflammatory Bowel Disease Download PDF
Bausch Health Companies Announces Participation In Upcoming Investor Conferences Date 04/24/19 Title Bausch Health Companies Announces Participation In Upcoming Investor Conferences Download PDF
Bausch + Lomb Reports More Than 9.2 Million Units Of Contact Lens Materials Diverted From Waste Stream Through ONE By ONE Recycling Program Date 04/22/19 Title Bausch + Lomb Reports More Than 9.2 Million Units Of Contact Lens Materials Diverted From Waste Stream Through ONE By ONE Recycling Program Download PDF
Bausch Health Companies Inc. Will Release First-Quarter 2019 Financial Results On May 6 Date 04/08/19 Title Bausch Health Companies Inc. Will Release First-Quarter 2019 Financial Results On May 6 Download PDF
Bausch + Lomb Announces The U.S. Launch Of LOTEMAX® SM (Loteprednol Etabonate Ophthalmic Gel) 0.38% For The Treatment Of Postoperative Inflammation And Pain Following Ocular Surgery Date 04/02/19 Title Bausch + Lomb Announces The U.S. Launch Of LOTEMAX® SM (Loteprednol Etabonate Ophthalmic Gel) 0.38% For The Treatment Of Postoperative Inflammation And Pain Following Ocular Surgery Download PDF
Salix Enters Into License Agreement With The University Of California To Develop And Commercialize Novel Compound For The Treatment Of Non-alcoholic Fatty Liver Disease And Non-alcoholic Steatohepatitis Date 04/01/19 Title Salix Enters Into License Agreement With The University Of California To Develop And Commercialize Novel Compound For The Treatment Of Non-alcoholic Fatty Liver Disease And Non-alcoholic Steatohepatitis Download PDF
Ortho Dermatologics Launches 2019 Aspire Higher Scholarship Program For Students With Dermatologic Conditions Date 03/11/19 Title Ortho Dermatologics Launches 2019 Aspire Higher Scholarship Program For Students With Dermatologic Conditions Download PDF
Bausch Health Announces Closing Of Senior Secured Notes And Add-On Unsecured Notes, As Well As Redemption Of Existing Senior Notes Date 03/08/19 Title Bausch Health Announces Closing Of Senior Secured Notes And Add-On Unsecured Notes, As Well As Redemption Of Existing Senior Notes Download PDF
Bausch Health Announces Early Tender Results And Early Settlement Date For Cash Tender Offers And Consent Solicitation For Senior Notes Date 03/08/19 Title Bausch Health Announces Early Tender Results And Early Settlement Date For Cash Tender Offers And Consent Solicitation For Senior Notes Download PDF
Bausch Health Completes Acquisition Of Certain Assets Of Synergy Pharmaceuticals Inc. Date 03/06/19 Title Bausch Health Completes Acquisition Of Certain Assets Of Synergy Pharmaceuticals Inc. Download PDF
Ortho Dermatologics To Present New Analyses At The American Academy Of Dermatology Annual Meeting Date 02/28/19 Title Ortho Dermatologics To Present New Analyses At The American Academy Of Dermatology Annual Meeting Download PDF
Bausch Health to Acquire Certain Assets of Synergy Pharmaceuticals Inc. Date 02/26/19 Title Bausch Health to Acquire Certain Assets of Synergy Pharmaceuticals Inc. Download PDF
Bausch + Lomb Announces FDA Approval Of LOTEMAX® SM (loteprednol Etabonate Ophthalmic Gel) 0.38% For The Treatment Of Postoperative Inflammation And Pain Following Ocular Surgery Date 02/25/19 Title Bausch + Lomb Announces FDA Approval Of LOTEMAX® SM (loteprednol Etabonate Ophthalmic Gel) 0.38% For The Treatment Of Postoperative Inflammation And Pain Following Ocular Surgery Download PDF
Bausch Health Announces Upsize Of Cash Tender Offers And Consent Solicitation To $1,500,000,000 Aggregate Purchase Price Date 02/22/19 Title Bausch Health Announces Upsize Of Cash Tender Offers And Consent Solicitation To $1,500,000,000 Aggregate Purchase Price Download PDF
Bausch Health Announces Pricing Of Private Offering Of Senior Secured Notes And Add-On Unsecured Notes Date 02/22/19 Title Bausch Health Announces Pricing Of Private Offering Of Senior Secured Notes And Add-On Unsecured Notes Download PDF
Bausch Health Announces Launch Of Private Offering Of Senior Secured Notes And Add-On Unsecured Notes Date 02/22/19 Title Bausch Health Announces Launch Of Private Offering Of Senior Secured Notes And Add-On Unsecured Notes Download PDF
Bausch Health Commences Cash Tender Offers And Consent Solicitation For Up To $1,250,000,000 Aggregate Purchase Price Date 02/22/19 Title Bausch Health Commences Cash Tender Offers And Consent Solicitation For Up To $1,250,000,000 Aggregate Purchase Price Download PDF
Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2018 Results And Provides 2019 Guidance Date 02/20/19 Title Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2018 Results And Provides 2019 Guidance Download PDF
Bausch Health Acquires Eton Pharmaceuticals' EM-100 Investigational Eye Drop For The Treatment Of Itchy Eyes Associated With Allergies Date 02/19/19 Title Bausch Health Acquires Eton Pharmaceuticals' EM-100 Investigational Eye Drop For The Treatment Of Itchy Eyes Associated With Allergies Download PDF
Bausch Health Provides Update For DUOBRII Filing Date 02/15/19 Title Bausch Health Provides Update For DUOBRII Filing Download PDF
Bausch + Lomb Receives 510(k) Clearance For Use Of The Tangible® Hydra-PEG® Custom Contact Lens Coating Technology On Several Of Its Boston® Gas Permeable Lens Materials And Zenlens™ Family Of Scleral Lenses Date 02/13/19 Title Bausch + Lomb Receives 510(k) Clearance For Use Of The Tangible® Hydra-PEG® Custom Contact Lens Coating Technology On Several Of Its Boston® Gas Permeable Lens Materials And Zenlens™ Family Of Scleral Lenses Download PDF
Bausch + Lomb Launches SightMatters.com To Help People Living With Age-Related Macular Degeneration Take Control Of Their Condition Date 02/04/19 Title Bausch + Lomb Launches SightMatters.com To Help People Living With Age-Related Macular Degeneration Take Control Of Their Condition Download PDF
Bausch Health Companies Announces Participation In Upcoming Investor Conferences Date 02/01/19 Title Bausch Health Companies Announces Participation In Upcoming Investor Conferences Download PDF
Bausch Health Reduces Debt By Additional $100 Million Date 01/29/19 Title Bausch Health Reduces Debt By Additional $100 Million Download PDF
Bausch Health Companies Inc. Will Release Fourth-Quarter And Full-Year 2018 Financial Results On February 20 Date 01/18/19 Title Bausch Health Companies Inc. Will Release Fourth-Quarter And Full-Year 2018 Financial Results On February 20 Download PDF
Bausch Health Provides Company Update At The 37th Annual J.P. Morgan Healthcare Conference Date 01/07/19 Title Bausch Health Provides Company Update At The 37th Annual J.P. Morgan Healthcare Conference Download PDF
Bausch Health To Present At The 37th Annual J.P. Morgan Healthcare Conference Date 01/02/19 Title Bausch Health To Present At The 37th Annual J.P. Morgan Healthcare Conference Download PDF
Bausch Health To Reduce Debt By Additional $76 Million, Bringing Total Debt Repayment In Quarter To Approximately $400 Million Date 12/19/18 Title Bausch Health To Reduce Debt By Additional $76 Million, Bringing Total Debt Repayment In Quarter To Approximately $400 Million Download PDF
Bausch Health Enters Into Definitive "Stalking Horse" Agreement To Acquire Substantially All The Assets Of Synergy Pharmaceuticals Inc. Date 12/12/18 Title Bausch Health Enters Into Definitive "Stalking Horse" Agreement To Acquire Substantially All The Assets Of Synergy Pharmaceuticals Inc. Download PDF
Bausch + Lomb Receives 510(K) Clearance From FDA For Bausch + Lomb Ultra® Multifocal For Astigmatism Contact Lenses Date 12/05/18 Title Bausch + Lomb Receives 510(K) Clearance From FDA For Bausch + Lomb Ultra® Multifocal For Astigmatism Contact Lenses Download PDF
Bausch Health Announces Redemption Of $200 Million Aggregate Principal Amount Of Its Outstanding 5.625% Senior Notes Due 2021 Date 11/30/18 Title Bausch Health Announces Redemption Of $200 Million Aggregate Principal Amount Of Its Outstanding 5.625% Senior Notes Due 2021 Download PDF
Bausch Health Announces Closing Of Incremental Amendment To Its Existing Credit Agreement And Redemption Of Its 7.500% Senior Notes Due 2021 Date 11/27/18 Title Bausch Health Announces Closing Of Incremental Amendment To Its Existing Credit Agreement And Redemption Of Its 7.500% Senior Notes Due 2021 Download PDF
Bausch Health Announces Early Tender Results And Early Settlement Date For Cash Tender Offer And Consent Solicitation For Any And All Of Its 7.500% Senior Notes Due 2021 Date 11/21/18 Title Bausch Health Announces Early Tender Results And Early Settlement Date For Cash Tender Offer And Consent Solicitation For Any And All Of Its 7.500% Senior Notes Due 2021 Download PDF
Bausch Health Announces Participation In Upcoming Investor Conferences Date 11/19/18 Title Bausch Health Announces Participation In Upcoming Investor Conferences Download PDF
Bausch + Lomb Reports More Than Five Million Units Of Contact Lens Materials Recycled By Second Anniversary Of ONE By ONE Recycling Program Date 11/15/18 Title Bausch + Lomb Reports More Than Five Million Units Of Contact Lens Materials Recycled By Second Anniversary Of ONE By ONE Recycling Program Download PDF
Bausch Health Will Expand Contact Lens Manufacturing Facilities In Rochester, NY And Waterford, Ireland Date 11/13/18 Title Bausch Health Will Expand Contact Lens Manufacturing Facilities In Rochester, NY And Waterford, Ireland Download PDF
Bausch Health Commences Cash Tender Offer And Consent Solicitation For Any And All Of Its 7.500% Senior Notes Due 2021 Date 11/07/18 Title Bausch Health Commences Cash Tender Offer And Consent Solicitation For Any And All Of Its 7.500% Senior Notes Due 2021 Download PDF
Bausch Health To Seek Incremental Amendment To Its Existing Credit Agreement Date 11/07/18 Title Bausch Health To Seek Incremental Amendment To Its Existing Credit Agreement Download PDF
Bausch Health To Participate At The Stifel 2018 Healthcare Conference Date 11/07/18 Title Bausch Health To Participate At The Stifel 2018 Healthcare Conference Download PDF
Bausch Health Announces U.S. Launch Of BRYHALI™ (halobetasol propionate) Lotion, 0.01%, For Plaque Psoriasis In Adults Date 11/07/18 Title Bausch Health Announces U.S. Launch Of BRYHALI™ (halobetasol propionate) Lotion, 0.01%, For Plaque Psoriasis In Adults Download PDF
Bausch Health Companies Inc. Announces Third-Quarter 2018 Results Date 11/06/18 Title Bausch Health Companies Inc. Announces Third-Quarter 2018 Results Download PDF
Bausch Health Launches ALTRENO™ (tretinoin) Lotion, 0.05% In The United States Date 10/30/18 Title Bausch Health Launches ALTRENO™ (tretinoin) Lotion, 0.05% In The United States Download PDF
Dr. Andrew C. Von Eschenbach Joins Bausch Health Board Of Directors Date 10/30/18 Title Dr. Andrew C. Von Eschenbach Joins Bausch Health Board Of Directors Download PDF
Salix And Alfasigma Will Initiate Late-Stage Program To Study Rifaximin In Patients With Postoperative Crohn's Disease Date 10/29/18 Title Salix And Alfasigma Will Initiate Late-Stage Program To Study Rifaximin In Patients With Postoperative Crohn's Disease Download PDF
Bausch + Lomb To Launch First-In-Class Surgical Support Applications For Stellaris Elite™ Vision Enhancement System On IBM Cloud Date 10/24/18 Title Bausch + Lomb To Launch First-In-Class Surgical Support Applications For Stellaris Elite™ Vision Enhancement System On IBM Cloud Download PDF
Bausch Health Announces Endowment With The University Of Missouri To Support Student Scholarships Date 10/23/18 Title Bausch Health Announces Endowment With The University Of Missouri To Support Student Scholarships Download PDF
Bausch Health's Ortho Dermatologics Business To Present New Scientific Data During The Fall Clinical Dermatology Conference Date 10/15/18 Title Bausch Health's Ortho Dermatologics Business To Present New Scientific Data During The Fall Clinical Dermatology Conference Download PDF
Bausch Health Companies Inc. Will Release Third-Quarter 2018 Financial Results On November 6 Date 10/12/18 Title Bausch Health Companies Inc. Will Release Third-Quarter 2018 Financial Results On November 6 Download PDF
Bausch Health Announces Publication Of Pivotal Phase 3 Efficacy And Safety Data On ALTRENO™ (tretinoin) Lotion, 0.05% In The Journal Of Drugs In Dermatology Date 10/11/18 Title Bausch Health Announces Publication Of Pivotal Phase 3 Efficacy And Safety Data On ALTRENO™ (tretinoin) Lotion, 0.05% In The Journal Of Drugs In Dermatology Download PDF
Salix to Present Clinical Data for XIFAXAN® (RIFAXIMIN) and PLENVU® at the American College of Gastroenterology Annual Meeting Date 10/08/18 Title Salix to Present Clinical Data for XIFAXAN® (RIFAXIMIN) and PLENVU® at the American College of Gastroenterology Annual Meeting Download PDF
Bausch Health's BRYHALI™(halobetasol propionate) Lotion, 0.01%, Receives Tentative FDA Approval For Plaque Psoriasis In Adults Date 10/08/18 Title Bausch Health's BRYHALI™(halobetasol propionate) Lotion, 0.01%, Receives Tentative FDA Approval For Plaque Psoriasis In Adults Download PDF
Ortho Dermatologics Announces Publication Of Pivotal Phase 3 Efficacy And Safety Data On Bryhali™* (Halobetasol Propionate) Lotion, 0.01% In The Journal Of Drugs In Dermatology Date 10/02/18 Title Ortho Dermatologics Announces Publication Of Pivotal Phase 3 Efficacy And Safety Data On Bryhali™* (Halobetasol Propionate) Lotion, 0.01% In The Journal Of Drugs In Dermatology Download PDF
Salix Resolves Legacy SEC Investigation With No Penalty Date 09/28/18 Title Salix Resolves Legacy SEC Investigation With No Penalty Download PDF
Bausch Health Releases First Annual Corporate Social Responsibility Report Date 09/27/18 Title Bausch Health Releases First Annual Corporate Social Responsibility Report Download PDF
Dova Pharmaceuticals and Salix Enter Into Exclusive Co-Promotion Agreement For DOPTELET® (Avatrombopag) Date 09/27/18 Title Dova Pharmaceuticals and Salix Enter Into Exclusive Co-Promotion Agreement For DOPTELET® (Avatrombopag) Download PDF
Bausch Health Announces Redemption Of $125 Million Aggregate Principal Amount Of Its Outstanding 7.50% Senior Notes Due 2021 Date 09/26/18 Title Bausch Health Announces Redemption Of $125 Million Aggregate Principal Amount Of Its Outstanding 7.50% Senior Notes Due 2021 Download PDF
Bausch Health Announces Participation In Upcoming Investor Conferences Date 09/24/18 Title Bausch Health Announces Participation In Upcoming Investor Conferences Download PDF
Bausch Health Announces Resolution Of XIFAXAN® Intellectual Property Litigation Date 09/12/18 Title Bausch Health Announces Resolution Of XIFAXAN® Intellectual Property Litigation Download PDF
Bausch Health Reduces Debt By Additional $107 Million, Eliminating All Remaining Mandatory Amortization For 2018 Date 09/11/18 Title Bausch Health Reduces Debt By Additional $107 Million, Eliminating All Remaining Mandatory Amortization For 2018 Download PDF
Salix Announces U.S. Launch of PLENVU®, the First and Only 1-Liter PEG Bowel Cleansing Preparation for Colonoscopies Date 09/11/18 Title Salix Announces U.S. Launch of PLENVU®, the First and Only 1-Liter PEG Bowel Cleansing Preparation for Colonoscopies Download PDF
LUMIFY™ Redness Reliever Eye Drops Honored By The National Association of Chain Drug Stores As Product Showcase Winner Date 09/10/18 Title LUMIFY™ Redness Reliever Eye Drops Honored By The National Association of Chain Drug Stores As Product Showcase Winner Download PDF
Bausch Health Companies To Participate At The Morgan Stanley Global Healthcare Conference Date 09/06/18 Title Bausch Health Companies To Participate At The Morgan Stanley Global Healthcare Conference Download PDF
Bausch + Lomb Announces Publication Of Pivotal Phase 3 Data On Loteprednol Etabonate Ophthalmic Gel, 0.38% In Journal Of Cataract And Refractive Surgery Date 09/05/18 Title Bausch + Lomb Announces Publication Of Pivotal Phase 3 Data On Loteprednol Etabonate Ophthalmic Gel, 0.38% In Journal Of Cataract And Refractive Surgery Download PDF
US WorldMeds And Salix Pharmaceuticals To Highlight Clinical Data For Opioid Withdrawal Treatment LUCEMYRA™ (lofexidine) At 2018 PAINWeek Conference Date 09/04/18 Title US WorldMeds And Salix Pharmaceuticals To Highlight Clinical Data For Opioid Withdrawal Treatment LUCEMYRA™ (lofexidine) At 2018 PAINWeek Conference Download PDF
FDA Accepts Resubmission Of New Drug Application For Duobrii™1 (Halobetasol Propionate And Tazarotene) Lotion Date 08/29/18 Title FDA Accepts Resubmission Of New Drug Application For Duobrii™1 (Halobetasol Propionate And Tazarotene) Lotion Download PDF
Ortho Dermatologics Receives FDA Approval For ALTRENO™ (tretinoin 0.05%) Lotion For Acne Date 08/24/18 Title Ortho Dermatologics Receives FDA Approval For ALTRENO™ (tretinoin 0.05%) Lotion For Acne Download PDF
Ortho Dermatologics Resubmits U.S. New Drug Application For DUOBRII™ (halobetasol propionate and tazarotene) Lotion Date 08/15/18 Title Ortho Dermatologics Resubmits U.S. New Drug Application For DUOBRII™ (halobetasol propionate and tazarotene) Lotion Download PDF
Ortho Dermatologics Announces 2018 Aspire Higher Scholarship Recipients Date 08/08/18 Title Ortho Dermatologics Announces 2018 Aspire Higher Scholarship Recipients Download PDF
Bausch Health Companies Inc. Announces Second-Quarter 2018 Results Date 08/07/18 Title Bausch Health Companies Inc. Announces Second-Quarter 2018 Results Download PDF
US WorldMeds and Salix Announce U.S. Launch of LUCEMYRA™ (lofexidine) 0.18 Mg Tablets Date 08/06/18 Title US WorldMeds and Salix Announce U.S. Launch of LUCEMYRA™ (lofexidine) 0.18 Mg Tablets Download PDF
Salix Expands Microbiome Research And Discovery Through Strategic Collaboration With Cedars-Sinai Medical Center Date 08/03/18 Title Salix Expands Microbiome Research And Discovery Through Strategic Collaboration With Cedars-Sinai Medical Center Download PDF
Bausch Health Companies Will Release Second-Quarter 2018 Financial Results On August 7 Date 07/18/18 Title Bausch Health Companies Will Release Second-Quarter 2018 Financial Results On August 7 Download PDF
Bausch Health Companies Inc. Begins Trading Today as "BHC" on NYSE and TSX Date 07/16/18 Title Bausch Health Companies Inc. Begins Trading Today as "BHC" on NYSE and TSX Download PDF
Bausch Health Companies Inc. completes name change Date 07/13/18 Title Bausch Health Companies Inc. completes name change Download PDF
Bausch + Lomb Announces U.S. FDA Filing Acceptance For Loteprednol Etabonate Ophthalmic Gel, 0.38% Date 07/09/18 Title Bausch + Lomb Announces U.S. FDA Filing Acceptance For Loteprednol Etabonate Ophthalmic Gel, 0.38% Download PDF
Salix And US WorldMeds Enter Into Exclusive Co-Promotion Agreement For Opioid Withdrawal Treatment LUCEMYRA™ (lofexidine) Date 06/26/18 Title Salix And US WorldMeds Enter Into Exclusive Co-Promotion Agreement For Opioid Withdrawal Treatment LUCEMYRA™ (lofexidine) Download PDF
FDA Issues Complete Response Letter For DUOBRII™ (Halobetasol Propionate and Tazarotene) Lotion Date 06/18/18 Title FDA Issues Complete Response Letter For DUOBRII™ (Halobetasol Propionate and Tazarotene) Lotion Download PDF
Bausch + Lomb Launches Soothe® Xtra Protection Preservative Free Lubricant Eye Drops Date 06/14/18 Title Bausch + Lomb Launches Soothe® Xtra Protection Preservative Free Lubricant Eye Drops Download PDF
Bausch + Lomb Introduces Ocuvite® Blue Light Eye Vitamins Date 06/12/18 Title Bausch + Lomb Introduces Ocuvite® Blue Light Eye Vitamins Download PDF
Valeant Announces Closing Of Amended And Restated Credit Agreement Transaction And Senior Notes Offering, As Well As Redemption Of Existing Senior Notes Date 06/01/18 Title Valeant Announces Closing Of Amended And Restated Credit Agreement Transaction And Senior Notes Offering, As Well As Redemption Of Existing Senior Notes Download PDF
Salix To Highlight New Clinical Data During Digestive Disease Week Date 05/31/18 Title Salix To Highlight New Clinical Data During Digestive Disease Week Download PDF
Valeant Announces Pricing Of Private Offering Of Notes Date 05/17/18 Title Valeant Announces Pricing Of Private Offering Of Notes Download PDF
Valeant Announces Launch Of Private Offering Of Notes And Upsize Of Term Loans Date 05/17/18 Title Valeant Announces Launch Of Private Offering Of Notes And Upsize Of Term Loans Download PDF
Valeant to Participate at the 2018 Barclays High Yield Bond and Syndicated Loan Conference Date 05/15/18 Title Valeant to Participate at the 2018 Barclays High Yield Bond and Syndicated Loan Conference Download PDF
Valeant To Participate At 2018 Bank Of America Merrill Lynch Healthcare Conference Date 05/10/18 Title Valeant To Participate At 2018 Bank Of America Merrill Lynch Healthcare Conference Download PDF
Valeant To Seek Refinancing of its Existing Credit Agreement Date 05/10/18 Title Valeant To Seek Refinancing of its Existing Credit Agreement Download PDF
Valeant Announces First-Quarter 2018 Results And Raises Revenue And Adjusted EBITDA (non-GAAP) Guidance Date 05/08/18 Title Valeant Announces First-Quarter 2018 Results And Raises Revenue And Adjusted EBITDA (non-GAAP) Guidance Download PDF
Valeant Will Become Bausch Health Companies Inc. Date 05/08/18 Title Valeant Will Become Bausch Health Companies Inc. Download PDF
Bausch + Lomb Launches LUMIFY, The First And Only OTC Redness Relieving Eye Drop With Low-Dose Brimonidine Date 05/07/18 Title Bausch + Lomb Launches LUMIFY, The First And Only OTC Redness Relieving Eye Drop With Low-Dose Brimonidine Download PDF
Salix Receives FDA Approval For PLENVU®, Next Generation 1-Liter Bowel Cleansing Preparation For Colonoscopies Date 05/07/18 Title Salix Receives FDA Approval For PLENVU®, Next Generation 1-Liter Bowel Cleansing Preparation For Colonoscopies Download PDF
Valeant To Participate At Goldman Sachs Third Annual Leveraged Finance Conference Date 05/03/18 Title Valeant To Participate At Goldman Sachs Third Annual Leveraged Finance Conference Download PDF
Summary Judgment Granted Upholding The Validity Of Formulation Patent Protecting RELISTOR® Injection Date 05/02/18 Title Summary Judgment Granted Upholding The Validity Of Formulation Patent Protecting RELISTOR® Injection Download PDF
Bausch + Lomb ULTRA® Contact Lenses Receive FDA Approval for Extended Wear Indication Date 05/02/18 Title Bausch + Lomb ULTRA® Contact Lenses Receive FDA Approval for Extended Wear Indication Download PDF
Valeant announces 2018 Annual Meeting Results Date 05/01/18 Title Valeant announces 2018 Annual Meeting Results Download PDF
Bausch + Lomb Will Present Scientific And Clinical Research During The Association For Research In Vision And Ophthalmology Meeting Date 04/27/18 Title Bausch + Lomb Will Present Scientific And Clinical Research During The Association For Research In Vision And Ophthalmology Meeting Download PDF
Bausch + Lomb Reports More Than Two Million Used Contact Lens Materials Recycled Through ONE By ONE Program Date 04/19/18 Title Bausch + Lomb Reports More Than Two Million Used Contact Lens Materials Recycled Through ONE By ONE Program Download PDF
Valeant Announces Redemption of $150 Million Aggregate Principal Amount of Its Outstanding 6.375% Senior Unsecured Notes Due 2020 Date 04/12/18 Title Valeant Announces Redemption of $150 Million Aggregate Principal Amount of Its Outstanding 6.375% Senior Unsecured Notes Due 2020 Download PDF
Arbitral Tribunal Decides In Favor Of Valeant In UCERIS Arbitration Date 04/12/18 Title Arbitral Tribunal Decides In Favor Of Valeant In UCERIS Arbitration Download PDF
Bausch + Lomb to Showcase New Scientific Data During the Annual Meeting of the American Society of Cataract and Refractive Surgery Date 04/11/18 Title Bausch + Lomb to Showcase New Scientific Data During the Annual Meeting of the American Society of Cataract and Refractive Surgery Download PDF
Valeant And One Of Its Subsidiaries Announce Expiration And Final Settlement Date For Cash Tender Offers For Senior Notes Date 04/10/18 Title Valeant And One Of Its Subsidiaries Announce Expiration And Final Settlement Date For Cash Tender Offers For Senior Notes Download PDF
Ortho Dermatologics Announces Publication Of Pivotal Efficacy And Safety Data For Psoriasis Treatment DUOBRII™ In The Journal of the American Academy of Dermatology Date 04/09/18 Title Ortho Dermatologics Announces Publication Of Pivotal Efficacy And Safety Data For Psoriasis Treatment DUOBRII™ In The Journal of the American Academy of Dermatology Download PDF
Valeant Will Release First-Quarter 2018 Financial Results On May 8 Date 04/06/18 Title Valeant Will Release First-Quarter 2018 Financial Results On May 8 Download PDF
Salix Launches 'Let's Talk 2' IBS Awareness Campaign Date 04/03/18 Title Salix Launches 'Let's Talk 2' IBS Awareness Campaign Download PDF
Valeant and One of its Subsidiaries Announce Early Tender Results and Early Settlement Date for Cash Tender Offers for Senior Notes Date 03/26/18 Title Valeant and One of its Subsidiaries Announce Early Tender Results and Early Settlement Date for Cash Tender Offers for Senior Notes Download PDF
Valeant And One Of Its Subsidiaries Announce Upsize Of Cash Tender Offers To $1,500,000,000 Outstanding Principal Amount Date 03/12/18 Title Valeant And One Of Its Subsidiaries Announce Upsize Of Cash Tender Offers To $1,500,000,000 Outstanding Principal Amount Download PDF
Valeant Announces Pricing of Private Offering of Senior Notes Date 03/12/18 Title Valeant Announces Pricing of Private Offering of Senior Notes Download PDF
Valeant Announces Launch Of Private Offering Of Senior Notes Date 03/12/18 Title Valeant Announces Launch Of Private Offering Of Senior Notes Download PDF
Valeant And One Of Its Subsidiaries Commence Cash Tender Offers For Up To $1,250,000,000 Outstanding Principal Amount Date 03/12/18 Title Valeant And One Of Its Subsidiaries Commence Cash Tender Offers For Up To $1,250,000,000 Outstanding Principal Amount Download PDF
Valeant To Participate At The 2018 Barclays Global Healthcare Conference Date 03/08/18 Title Valeant To Participate At The 2018 Barclays Global Healthcare Conference Download PDF
Valeant Announces Fourth-Quarter And Full-Year 2017 Results And Provides 2018 Guidance Date 02/28/18 Title Valeant Announces Fourth-Quarter And Full-Year 2017 Results And Provides 2018 Guidance Download PDF
Valeant Announces Redemption Of Remaining $71 Million Aggregate Principal Amount Of Its Outstanding 7.00% Senior Unsecured Notes Due 2020 Date 02/28/18 Title Valeant Announces Redemption Of Remaining $71 Million Aggregate Principal Amount Of Its Outstanding 7.00% Senior Unsecured Notes Due 2020 Download PDF
Valeant Announces Licensing Agreement With Kaken Pharmaceutical Co., Ltd. To Develop And Commercialize New Chemical Entity For Psoriasis Date 02/27/18 Title Valeant Announces Licensing Agreement With Kaken Pharmaceutical Co., Ltd. To Develop And Commercialize New Chemical Entity For Psoriasis Download PDF
Ortho Dermatologics Presents An Analysis Of SILIQTM (Brodalumab) Injection Phase 3 Data On Disease-Related Anxiety And Depression In Patients With Moderate-To-Severe Plaque Psoriasis Date 02/16/18 Title Ortho Dermatologics Presents An Analysis Of SILIQTM (Brodalumab) Injection Phase 3 Data On Disease-Related Anxiety And Depression In Patients With Moderate-To-Severe Plaque Psoriasis Download PDF
Ortho Dermatologics Announces U.S. FDA Filing Acceptance For JEMDEL™ Plaque Psoriasis Treatment Date 02/14/18 Title Ortho Dermatologics Announces U.S. FDA Filing Acceptance For JEMDEL™ Plaque Psoriasis Treatment Download PDF
Salix provides update on FDA submission for PLENVU®* Date 02/09/18 Title Salix provides update on FDA submission for PLENVU®* Download PDF
Salix provides update on FDA submission for PLENVU®* Date 02/09/18 Title Salix provides update on FDA submission for PLENVU®* Download PDF
Valeant Will Release Fourth-Quarter And Full-Year 2017 Financial Results On February 28 Date 02/06/18 Title Valeant Will Release Fourth-Quarter And Full-Year 2017 Financial Results On February 28 Download PDF
Valeant Will Reduce Debt By An Additional $200 Million Date 01/25/18 Title Valeant Will Reduce Debt By An Additional $200 Million Download PDF
Ortho Dermatologics Announces U.S. FDA Filing Acceptance For IDP-121 Acne Treatment In Lotion Form Date 01/12/18 Title Ortho Dermatologics Announces U.S. FDA Filing Acceptance For IDP-121 Acne Treatment In Lotion Form Download PDF
Valeant Provides Company Update At The 36th Annual J.P. Morgan Healthcare Conference Date 01/09/18 Title Valeant Provides Company Update At The 36th Annual J.P. Morgan Healthcare Conference Download PDF
Bausch + Lomb Receives CE Mark From The European Commission For The Stellaris Elite™ Vision Enhancement System, Including The Vitesse™ Vitrectomy System Date 01/08/18 Title Bausch + Lomb Receives CE Mark From The European Commission For The Stellaris Elite™ Vision Enhancement System, Including The Vitesse™ Vitrectomy System Download PDF
Valeant Pays Down $300 Million Of Senior Secured Term Loans Date 01/03/18 Title Valeant Pays Down $300 Million Of Senior Secured Term Loans Download PDF
Valeant To Present At The 36th Annual J.P. Morgan Healthcare Conference Date 01/03/18 Title Valeant To Present At The 36th Annual J.P. Morgan Healthcare Conference Download PDF
Powered by Sitecore